Health Services Research & Development

Veterans Crisis Line Badge
Go to the ORD website
Go to the QUERI website

Citations Database Search Results

Download these results to MS Excel

630 records found for:
Title = Opioid
Year =

  1. Lobo CP, Cochran G, Chang CH, Gellad WF, Gordon AJ, Jalal H, Lo-Ciganic WH, Karp JF, Kelley D, Donohue JM. Associations Between the Specialty of Opioid Prescribers and Opioid Addiction, Misuse, and Overdose Outcomes. Pain medicine (Malden, Mass.). 2019 Oct 18.
  2. Moyo P, Gellad WF, Sabik LM, Cochran GT, Cole ES, Gordon AJ, Kelley DK, Donohue JM. Opioid Prescribing Safety Measures in Medicaid Enrollees With and Without Cancer. American journal of preventive medicine. 2019 Oct 1; 57(4):540-544.
  3. Thornhill MH, Suda KJ, Durkin MJ, Lockhart PB. Is it time US dentistry ended its opioid dependence? Journal of the American Dental Association (1939). 2019 Oct 1; 150(10):883-889.
  4. Midboe AM, Byrne T, Smelson D, Jasuja G, McInnes K, Troszak LK. The Opioid Epidemic In Veterans Who Were Homeless Or Unstably Housed. Health affairs (Project Hope). 2019 Aug 1; 38(8):1289-1297.
  5. Klueh MP, Sloss KR, Dossett LA, Englesbe MJ, Waljee JF, Brummett CM, Lagisetty PA, Lee JS. Postoperative opioid prescribing is not my job: A qualitative analysis of care transitions. Surgery. 2019 Jul 11.
  6. Lagisetty PA, Healy N, Garpestad C, Jannausch M, Tipirneni R, Bohnert ASB. Access to Primary Care Clinics for Patients With Chronic Pain Receiving Opioids. JAMA Network Open. 2019 Jul 3; 2(7):e196928.
  7. Larochelle MR, Bohnert ASB. Opportunities to Address First Opioid Prescriptions to Reduce Incident Long-Term Opioid Use. Annals of internal medicine. 2019 Jul 16; 171(2):129-130.
  8. Haffajee RL, Lin LA, Bohnert ASB, Goldstick JE. Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder. JAMA Network Open. 2019 Jun 5; 2(6):e196373.
  9. Lagisetty PA, Bohnert A. Role of an Accurate Treatment Locator and Cash-Only Practices in Access to Buprenorphine for Opioid Use Disorders. [Editorial]. Annals of internal medicine. 2019 Jul 2; 171(1):58-59.
  10. Hadlandsmyth K, Stewart KR, Paez MB, Steffen M, Meth M, Reisinger HS, Mosher HJ. Patient Perspectives on Opioids: Views of Inpatient Veterans with Chronic Pain. Pain medicine (Malden, Mass.). 2019 Jun 1; 20(6):1141-1147.
  11. Yarborough BJH, Stumbo SP, Stoneburner A, Smith N, Dobscha SK, Deyo RA, Morasco BJ. Correlates of Benzodiazepine Use and Adverse Outcomes Among Patients with Chronic Pain Prescribed Long-term Opioid Therapy. Pain medicine (Malden, Mass.). 2019 Jun 1; 20(6):1148-1155.
  12. Barnett ML, Zhao X, Fine MJ, Thorpe CT, Sileanu FE, Cashy JP, Mor MK, Radomski TR, Hausmann LRM, Good CB, Gellad WF. Emergency Physician Opioid Prescribing and Risk of Long-term Use in the Veterans Health Administration: an Observational Analysis. Journal of general internal medicine. 2019 Aug 1; 34(8):1522-1529.
  13. Lin LA, Peltzman T, McCarthy JF, Oliva EM, Trafton JA, Bohnert ASB. Changing Trends in Opioid Overdose Deaths and Prescription Opioid Receipt Among Veterans. American journal of preventive medicine. 2019 Jul 1; 57(1):106-110.
  14. Lund BC, Ohl ME, Hadlandsmyth K, Mosher HJ. Regional and Rural-Urban Variation in Opioid Prescribing in the Veterans Health Administration. Military medicine. 2019 May 21.
  15. Wilson MP, Cucciare MA, Porter A, Chalmers CE, Mullinax S, Mancino M, Oliveto AH. The utility of a statewide prescription drug-monitoring database vs the Current Opioid Misuse Measure for identifying drug-aberrant behaviors in emergency department patients already on opioids. The American journal of emergency medicine. 2019 May 17; 158250.
  16. Mosher HJ. Nudging Our Way to Opioid 'Right-Sizing'. Joint Commission Journal on Quality and Patient Safety. 2019 Jun 1; 45(6):414-415.
  17. Chua KP, Brummett CM, Conti RM, Haffajee RL, Prosser LA, Bohnert ASB. Assessment of Prescriber and Pharmacy Shopping Among the Family Members of Patients Prescribed Opioids. JAMA Network Open. 2019 May 3; 2(5):e193673.
  18. Suda KJ, Durkin MJ, Calip GS, Gellad WF, Kim H, Lockhart PB, Rowan SA, Thornhill MH. Comparison of Opioid Prescribing by Dentists in the United States and England. JAMA Network Open. 2019 May 3; 2(5):e194303.
  19. Bixler FR, Radomski TR, Zickmund SL, Roman KM, Hausmann LRM, Thorpe CT, Hale JA, Sileanu FE, Gellad WF. Primary care physicians' perspectives on Veterans who obtain prescription opioids from multiple healthcare systems. Journal of opioid management. 2019 May 1; 15(3):183-191.
  20. Frank JW, Carey E, Nolan C, Kerns RD, Sandbrink F, Gallagher R, Ho PM. Increased Nonopioid Chronic Pain Treatment in the Veterans Health Administration, 2010-2016. Pain medicine (Malden, Mass.). 2019 May 1; 20(5):869-877.
  21. Mudumbai SC, Lewis ET, Oliva EM, Chung PD, Harris B, Trafton J, Mariano ER, Wagner T, Clark JD, Stafford RS. Overdose Risk Associated with Opioid Use upon Hospital Discharge in Veterans Health Administration Surgical Patients. Pain medicine (Malden, Mass.). 2019 May 1; 20(5):1020-1031.
  22. Wyse JJ, Ganzini L, Dobscha SK, Krebs EE, Morasco BJ. Setting Expectations, Following Orders, Safety, and Standardization: Clinicians' Strategies to Guide Difficult Conversations About Opioid Prescribing. Journal of general internal medicine. 2019 Jul 1; 34(7):1200-1206.
  23. Harbaugh CM, Lee JS, Chua KP, Kenney B, Iwashyna TJ, Englesbe MJ, Brummett CM, Bohnert AS, Waljee JF. Association Between Long-term Opioid Use in Family Members and Persistent Opioid Use After Surgery Among Adolescents and Young Adults. JAMA surgery. 2019 Apr 17; 154(4):e185838.
  24. Joudrey PJ, Khan MR, Wang EA, Scheidell JD, Edelman EJ, McInnes DK, Fox AD. A conceptual model for understanding post-release opioid-related overdose risk. Addiction science & clinical practice. 2019 Apr 15; 14(1):17.
  25. Bohnert ASB, Ilgen MA. Understanding Links among Opioid Use, Overdose, and Suicide. Reply. [Letter to the Editor]. The New England journal of medicine. 2019 Apr 4; 380(14):1380.
  26. Kroenke K, Alford DP, Argoff C, Canlas B, Covington E, Frank JW, Haake KJ, Hanling S, Hooten WM, Kertesz SG, Kravitz RL, Krebs EE, Stanos SP, Sullivan M. Challenges with Implementing the Centers for Disease Control and Prevention Opioid Guideline: A Consensus Panel Report. Pain medicine (Malden, Mass.). 2019 Apr 1; 20(4):724-735.
  27. Morrow DJ, Fischer EP, Walder AM, Jubran NI. Nonopioid Alternatives to Addressing Pain Intensity: A Retrospective Look at 2 Noninvasive Pain Treatment Devices. Federal practitioner : for the health care professionals of the VA, DoD, and PHS. 2019 Apr 1; 36(4):181-187.
  28. Cole ES, DiDomenico E, Cochran G, Gordon AJ, Gellad WF, Pringle J, Warwick J, Chang CH, Kim JY, Kmiec J, Kelley D, Donohue JM. The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder. Journal of general internal medicine. 2019 Jun 1; 34(6):936-943.
  29. Moyo P, Zhao X, Thorpe CT, Thorpe JM, Sileanu FE, Cashy JP, Hale JA, Mor MK, Radomski TR, Donohue JM, Hausmann LRM, Hanlon JT, Good CB, Fine MJ, Gellad WF. Dual Receipt of Prescription Opioids From the Department of Veterans Affairs and Medicare Part D and Prescription Opioid Overdose Death Among Veterans: A Nested Case-Control Study. Annals of internal medicine. 2019 Apr 2; 170(7):433-442.
  30. Frakt AB. The Opioid Dilemma: Saving Lives in the Long Run Can Take Lives in the Short Run. The New York Times. 2019 Mar 4: The Upshot.
  31. Brummett CM, Moser SE, Nallamothu BK. Errors in Analysis in Study of New Persistent Opioid Use After Surgery. JAMA surgery. 2019 Mar 1; 154(3):268-269.
  32. Lo-Ciganic WH, Huang JL, Zhang HH, Weiss JC, Wu Y, Kwoh CK, Donohue JM, Cochran G, Gordon AJ, Malone DC, Kuza CC, Gellad WF. Evaluation of Machine-Learning Algorithms for Predicting Opioid Overdose Risk Among Medicare Beneficiaries With Opioid Prescriptions. JAMA Network Open. 2019 Mar 1; 2(3):e190968.
  33. Dasinger EA, Graham LA, Wahl TS, Richman JS, Baker SJ, Hawn MT, Hernandez-Boussard T, Rosen AK, Mull HJ, Copeland LA, Whittle JC, Burns EA, Morris MS. Preoperative opioid use and postoperative pain associated with surgical readmissions. American journal of surgery. 2019 Nov 1; 218(5):828-835.
  34. Chinman M, Gellad WF, McCarthy S, Gordon AJ, Rogal S, Mor MK, Hausmann LRM. Protocol for evaluating the nationwide implementation of the VA Stratification Tool for Opioid Risk Management (STORM). Implementation science : IS. 2019 Jan 18; 14(1):5.
  35. Minegishi T, Frakt AB, Garrido MM, Gellad WF, Hausmann LRM, Lewis ET, Pizer SD, Trafton JA, Oliva EM. Randomized program evaluation of the Veterans Health Administration Stratification Tool for Opioid Risk Mitigation (STORM): A research and clinical operations partnership to examine effectiveness. Substance Abuse. 2019 Jan 8; 1-6.
  36. Dasinger EA, Branch-Elliman W, Pizer SD, Abdulkerim H, Rosen AK, Charns MP, Hawn MT, Itani KMF, Mull HJ. Association between postoperative opioid use and outpatient surgical adverse events. American journal of surgery. 2019 Apr 1; 217(4):605-612.
  37. Bohnert ASB, Ilgen MA. Understanding Links among Opioid Use, Overdose, and Suicide. The New England journal of medicine. 2019 Jan 3; 380(1):71-79.
  38. Bohnert ASB, Larochelle MR. Are Temporal Trends Important Measures of Opioid-prescribing Risk?. Journal of addiction medicine. 2019 Jan 1; 13(1):5-6.
  39. Morasco BJ, Krebs EE, Adams MH, Hyde S, Zamudio J, Dobscha SK. Clinician Response to Aberrant Urine Drug Test Results of Patients Prescribed Opioid Therapy for Chronic Pain. The Clinical Journal of Pain. 2019 Jan 1; 35(1):1-6.
  40. Vu JV, Cron DC, Lee JS, Gunaseelan V, Lagisetty P, Wixson M, Englesbe MJ, Brummett CM, Waljee JF. Classifying Preoperative Opioid Use for Surgical Care. Annals of surgery. 2018 Dec 26.
  41. Dayer LE, Painter JT, McCain K, King J, Cullen J, Foster HR. A recent history of opioid use in the US: Three decades of change. Substance use & misuse. 2018 Dec 21; 54(2):331-339.
  42. Hagedorn H, Kenny M, Gordon AJ, Ackland PE, Noorbaloochi S, Yu W, Harris AHS. Advancing pharmacological treatments for opioid use disorder (ADaPT-OUD): protocol for testing a novel strategy to improve implementation of medication-assisted treatment for veterans with opioid use disorders in low-performing facilities. Addiction science & clinical practice. 2018 Dec 13; 13(1):25.
  43. Rose AJ, McBain R, Schuler MS, LaRochelle MR, Ganz DA, Kilambi V, Stein BD, Bernson D, Chui KKH, Land T, Walley AY, Stopka TJ. Effect of Age on Opioid Prescribing, Overdose, and Mortality in Massachusetts, 2011 to 2015. Journal of the American Geriatrics Society. 2019 Jan 1; 67(1):128-132.
  44. Hadlandsmyth K, Lund BC, Mosher HJ. Associations between initial opioid exposure and the likelihood for long-term use. Journal of the American Pharmacists Association : JAPhA. 2019 Jan 1; 59(1):17-22.
  45. Wyse JJ, Ganzini L, Dobscha SK, Krebs EE, Zamudio J, Morasco BJ. Clinical Strategies for the Treatment and Management of Patients Prescribed Long-term Opioid Therapy. Pain medicine (Malden, Mass.). 2018 Nov 2.
  46. Frakt AB, Humphries K. Just Say No to Opioids? Ads Could Actually Make Things Worse. The New York Times. 2018 Nov 1: The Upshot: A3.
  47. Frost MC, Williams EC, Kingston S, Banta-Green CJ. Interest in Getting Help to Reduce or Stop Substance Use Among Syringe Exchange Clients Who Use Opioids. Journal of addiction medicine. 2018 Nov 1; 12(6):428-434.
  48. Jasuja GK, Ameli O, Miller DR, Land T, Bernson D, Rose AJ, Berlowitz DR, Smelson DA. Overdose risk for veterans receiving opioids from multiple sources. The American journal of managed care. 2018 Nov 1; 24(11):536-540.
  49. Kennedy LC, Binswanger IA, Mueller SR, Levy C, Matlock DD, Calcaterra SL, Koester S, Frank JW. "Those Conversations in My Experience Don't Go Well": A Qualitative Study of Primary Care Provider Experiences Tapering Long-term Opioid Medications. Pain medicine (Malden, Mass.). 2018 Nov 1; 19(11):2201-2211.
  50. Sowicz TJ, Gordon AJ, Gellad WF, Zhao X, Zhang H, Emmendorfer T, Good CB. High Variability of Opioid Prescribing Within and Across Emergency Departments in the US Veterans Health Administration. Journal of general internal medicine. 2018 Nov 1; 33(11):1831-1832.
  51. Crockett S, Greer KB, Sultan S. Opioid-Induced Constipation (OIC) Guideline. Gastroenterology. 2019 Jan 1; 156(1):228.
  52. Moyo P, Zhao X, Thorpe CT, Thorpe JM, Sileanu FE, Cashy JP, Hale JA, Mor MK, Radomski TR, Donohue JM, Hausmann LRM, Hanlon JT, Good CB, Fine MJ, Gellad WF. Patterns of opioid prescriptions received prior to unintentional prescription opioid overdose death among Veterans. Research in social & administrative pharmacy : RSAP. 2019 Aug 1; 15(8):1007-1013.
  53. Rogal SS, Beste LA, Youk A, Fine MJ, Ketterer B, Zhang H, Leipertz S, Chartier M, Good CB, Kraemer KL, Chinman M, Morgan T, Gellad WF. Characteristics of Opioid Prescriptions to Veterans With Cirrhosis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2019 May 1; 17(6):1165-1174.e3.
  54. Hanson B, Siddique SM, Scarlett Y, Sultan S, American Gastroenterological Association Institute Clinical Guidelines Committee. American Gastroenterological Association Institute Technical Review on the Medical Management of Opioid-Induced Constipation. Gastroenterology. 2019 Jan 1; 156(1):229-253.e5.
  55. Brescia AA, Harrington CA, Mazurek AA, Ward ST, Lee JSJ, Hu HM, Brummett CM, Waljee JF, Lagisetty PA, Lagisetty KH. Factors Associated With New Persistent Opioid Usage After Lung Resection. The Annals of thoracic surgery. 2019 Feb 1; 107(2):363-368.
  56. Carico R, Zhao X, Thorpe CT, Thorpe JM, Sileanu FE, Cashy JP, Hale JA, Mor MK, Radomski TR, Hausmann LRM, Donohue JM, Suda KJ, Stroupe K, Hanlon JT, Good CB, Fine MJ, Gellad WF. Receipt of Overlapping Opioid and Benzodiazepine Prescriptions Among Veterans Dually Enrolled in Medicare Part D and the Department of Veterans Affairs: A Cross-sectional Study. Annals of internal medicine. 2018 Nov 6; 169(9):593-601.
  57. McPherson S, Lederhos Smith C, Dobscha SK, Morasco BJ, Demidenko MI, Meath THA, Lovejoy TI. Changes in pain intensity after discontinuation of long-term opioid therapy for chronic noncancer pain. Pain. 2018 Oct 1; 159(10):2097-2104.
  58. Vanneman ME, Larson MJ, Chen C, Adams RS, Williams TV, Meerwijk E, Harris AHS. Treatment of Low Back Pain With Opioids and Nonpharmacologic Treatment Modalities for Army Veterans. Medical care. 2018 Oct 1; 56(10):855-861.
  59. Hanks D. In Progress-4: Improving Opioid Safety. 2018 Sep 24; 3(4).
  60. Timko C, Cucciare MA. Commentary on Socias et al. (2018): Clinical research perspectives on cannabis use in opioid agonist treatment. Addiction (Abingdon, England). 2018 Dec 1; 113(12):2259-2260.
  61. Wren AA, Bensen R, Sceats L, Dehghan M, Yu H, Wong JJ, MacIsaac D, Sellers ZM, Kin C, Park KT. Starting Young: Trends in Opioid Therapy Among US Adolescents and Young Adults With Inflammatory Bowel Disease in the Truven MarketScan Database Between 2007 and 2015. Inflammatory Bowel Diseases. 2018 Sep 15; 24(10):2093-2103.
  62. Meshberg-Cohen S, Black AC, DeViva JC, Petrakis IL, Rosen MI. Trauma treatment for veterans in buprenorphine maintenance treatment for opioid use disorder. Addictive Behaviors. 2019 Feb 1; 89:29-34.
  63. Ilgen M. Pain, Opioids, and Suicide Mortality in the United States. Annals of internal medicine. 2018 Oct 2; 169(7):498-499.
  64. Herzig SJ, Mosher HJ, Calcaterra SL, Nuckols TK. Reply to "In Reference to 'Improving the Safety of Opioid Use for Acute Noncancer Pain in Hospitalized Adults: A Consensus Statement from the Society of Hospital Medicine'". Journal of hospital medicine. 2018 Sep 1; 13(10):728.
  65. Leapman MS, DeRycke E, Skanderson M, Becker WC, Makarov DV, Gross CP, Driscoll M, Motamedinia P, Bathulapalli H, Mattocks K, Brandt CA, Haskell S, Bastian LA. Variation in National Opioid Prescribing Patterns Following Surgery for Kidney Stones. Pain medicine (Malden, Mass.). 2018 Sep 1; 19(suppl_1):S12-S18.
  66. Lisi AJ, Corcoran KL, DeRycke EC, Bastian LA, Becker WC, Edmond SN, Goertz CM, Goulet JL, Haskell SG, Higgins DM, Kawecki T, Kerns RD, Mattocks K, Ramsey C, Ruser CB, Brandt CA. Opioid Use Among Veterans of Recent Wars Receiving Veterans Affairs Chiropractic Care. Pain medicine (Malden, Mass.). 2018 Sep 1; 19(suppl_1):S54-S60.
  67. Midboe AM, Wu J, Erhardt T, Carmichael JM, Bounthavong M, Christopher MLD, Gale RC. Academic Detailing to Improve Opioid Safety: Implementation Lessons from a Qualitative Evaluation. Pain medicine (Malden, Mass.). 2018 Sep 1; 19(suppl_1):S46-S53.
  68. Oldfield BJ, Edens EL, Agnoli A, Bone CW, Cervone DJ, Edmond SN, Manhapra A, Sellinger JJ, Becker WC. Multimodal Treatment Options, Including Rotating to Buprenorphine, Within a Multidisciplinary Pain Clinic for Patients on Risky Opioid Regimens: A Quality Improvement Study. Pain medicine (Malden, Mass.). 2018 Sep 1; 19(suppl_1):S38-S45.
  69. Bohnert ASB, Guy GP, Losby JL. Opioid Prescribing in the United States Before and After the Centers for Disease Control and Prevention's 2016 Opioid Guideline. Annals of internal medicine. 2018 Sep 18; 169(6):367-375.
  70. Kertesz SG, Gordon AJ. A crisis of opioids and the limits of prescription control: United States. Addiction (Abingdon, England). 2019 Jan 1; 114(1):169-180.
  71. Pitt AL, Humphreys K, Brandeau ML. Modeling Health Benefits and Harms of Public Policy Responses to the US Opioid Epidemic. American journal of public health. 2018 Oct 1; 108(10):1394-1400.
  72. Barry DT, Marshall BDL, Becker WC, Gordon AJ, Crystal S, Kerns RD, Gaither JR, Gordon KS, Justice AC, Fiellin DA, Edelman EJ. Duration of opioid prescriptions predicts incident nonmedical use of prescription opioids among U.S. veterans receiving medical care. Drug and Alcohol Dependence. 2018 Oct 1; 191:348-354.
  73. Riddle DL, Slover JD, Ang DC, Bair MJ, Kroenke K, Perera RA, Dumenci L. Opioid use prior to knee arthroplasty in patients who catastrophize about their pain: preoperative data from a multisite randomized clinical trial. Journal of pain research. 2018 Aug 21; 11:1549-1557.
  74. Sasson C, Smith J, Kessler C, Haukoos J, Himstreet J, Christopher M, Emmendorfer T. Variability in opioid prescribing in veterans affairs emergency departments and urgent cares. The American journal of emergency medicine. 2019 Jun 1; 37(6):1044-1047.
  75. Lowenstein M, Grande D, Delgado MK. Opioid Prescribing Limits for Acute Pain - Striking the Right Balance. The New England journal of medicine. 2018 Aug 9; 379(6):504-506.
  76. Carlson KF, Gilbert TA, Morasco BJ, Wright D, Otterloo JV, Herrndorf A, Cook LJ. Linkage of VA and State Prescription Drug Monitoring Program Data to Examine Concurrent Opioid and Sedative-Hypnotic Prescriptions among Veterans. Health services research. 2018 Dec 1; 53 Suppl 3:5285-5308.
  77. Krebs EE, Gravely A, Noorbaloochi S. Opioids vs Nonopioids for Chronic Back, Hip, or Knee Pain-Reply. [Letter to the Editor]. JAMA. 2018 Aug 7; 320(5):508-509.
  78. Hulen E, Saha S, Morasco BJ, Zeigler C, Mackey K, Edwards ST. Sources of Distress in Primary Care Opioid Management and the Role of a Controlled Substance Review Group: A Qualitative Study. Pain medicine (Malden, Mass.). 2018 Aug 1; 19(8):1570-1577.
  79. Humphreys K. Reconciling the Present and the Future in Opioid Prescription Policy: An Ethical Dilemma. Pain medicine (Malden, Mass.). 2018 Aug 1; 19(8):1514-1515.
  80. Shayegani R, Pugh MJ, Kazanis W, Wilkening GL. Reducing coprescriptions of benzodiazepines and opioids in a veteran population. The American journal of managed care. 2018 Aug 1; 24(8):e265-e269.
  81. Giannitrapani KF, Glassman PA, Vang D, McKelvey JC, Thomas Day R, Dobscha SK, Lorenz KA. Expanding the role of clinical pharmacists on interdisciplinary primary care teams for chronic pain and opioid management. BMC family practice. 2018 Jul 3; 19(1):107.
  82. Wyse JJ, Morasco BJ, Dobscha SK, Demidenko MI, Meath THA, Lovejoy TI. Provider reasons for discontinuing long-term opioid therapy following aberrant urine drug tests differ based on the type of substance identified. Journal of opioid management. 2018 Jul 1; 14(4):295-303.
  83. Minegishi T, Garrido MM, Pizer SD, Frakt AB. Effectiveness of policy and risk targeting for opioid-related risk mitigation: a randomised programme evaluation with stepped-wedge design. BMJ open. 2018 Jun 27; 8(6):e020097.
  84. Ma J, Bao YP, Wang RJ, Su MF, Liu MX, Li JQ, Degenhardt L, Farrell M, Blow FC, Ilgen M, Shi J, Lu L. Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis. Molecular Psychiatry. 2018 Jun 22.
  85. Young SD, Zheng K, Chu LF, Humphreys K. Internet searches for opioids predict future emergency department heroin admissions. Drug and Alcohol Dependence. 2018 Sep 1; 190:166-169.
  86. Koppen L, Suda KJ, Rowan S, McGregor J, Evans CT. Dentists' prescribing of antibiotics and opioids to Medicare Part D beneficiaries: Medications of high impact to public health. Journal of the American Dental Association (1939). 2018 Aug 1; 149(8):721-730.
  87. Hawkins EJ. Opioid and Benzodiazepine Co-prescribing and Mortality among VA Patients with Posttraumatic Stress Disorder. HSR&D CyberSeminars [Cyberseminar]. HSR&D. 2018 Jun 11.
  88. Klueh MP, Hu HM, Howard RA, Vu JV, Harbaugh CM, Lagisetty PA, Brummett CM, Englesbe MJ, Waljee JF, Lee JS. Transitions of Care for Postoperative Opioid Prescribing in Previously Opioid-Naïve Patients in the USA: a Retrospective Review. Journal of general internal medicine. 2018 Oct 1; 33(10):1685-1691.
  89. Darnall BD, Humphreys KN. An experimental method for assessing whether marijuana use reduces opioid use in patients with chronic pain. [Letter to the Editor]. Addiction (Abingdon, England). 2018 Aug 1; 113(8):1552-1553.
  90. Lewis ET. Data-Based Case Reviews of Patients with Opioid Related Risk Factors as a Tool to Prevent Overdose and Suicide. SoSP (Suicide Prevention) [Cyberseminar]. HSR&D. 2018 Jun 4.
  91. Butler JM, Becker WC, Humphreys K. Big Data and the Opioid Crisis: Balancing Patient Privacy with Public Health. The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics. 2018 Jun 1; 46(2):440-453.
  92. Minegishi T, Frakt A. Reducing Long-term Opioid Use in the Veterans Health Administration. [Editorial]. Journal of general internal medicine. 2018 Jun 1; 33(6):781-782.
  93. Saraswathula A, Chen MM, Mudumbai SC, Whittemore AS, Divi V. Persistent Postoperative Opioid Use in Older Head and Neck Cancer Patients. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2019 Mar 1; 160(3):380-387.
  94. Ashrafioun L, Allen KD, Pigeon WR. Utilization of complementary and integrative health services and opioid therapy by patients receiving Veterans Health Administration pain care. Complementary therapies in medicine. 2018 Aug 1; 39:8-13.
  95. Dindo L, Zimmerman MB, Hadlandsmyth K, StMarie B, Embree J, Marchman J, Tripp-Reimer T, Rakel B. Acceptance and Commitment Therapy for Prevention of Chronic Postsurgical Pain and Opioid Use in At-Risk Veterans: A Pilot Randomized Controlled Study. The journal of pain : official journal of the American Pain Society. 2018 Oct 1; 19(10):1211-1221.
  96. Cohen-Mekelburg S, Rosenblatt R, Gold S, Burakoff R, Waljee A, Saini S, Schackman BR, Scherl E, Crawford C. The Impact of Opioid Epidemic Trends on Hospitalized Inflammatory Bowel Disease Patients. Journal of Crohn's & colitis. 2018 May 7.
  97. Frank JW, Gilmartin HM. Pain Management and Opioid Safety. https://www.hsrd.research.va.gov/news/podcasts/listen.cfm?ID=28; 2018 May 4. Available from: https://www.hsrd.research.va.gov/news/podcasts/listen.cfm?ID=28.
  98. Hecht MI, Hanks D, Gilmartin HM, Frank JW. Podcast: Pain Management and Opioid Safety. 2018 May 4. 2 (10). Available from: https://www.hsrd.research.va.gov/news/podcasts/default.cfm.
  99. Alzeer AH, Jones J, Bair MJ. Review of Factors, Methods, and Outcome Definition in Designing Opioid Abuse Predictive Models. Pain medicine (Malden, Mass.). 2018 May 1; 19(5):997-1009.
  100. Carey EP, Nolan C, Kerns RD, Ho PM, Frank JW. Association Between Facility-Level Utilization of Non-pharmacologic Chronic Pain Treatment and Subsequent Initiation of Long-Term Opioid Therapy. Journal of general internal medicine. 2018 May 1; 33(Suppl 1):38-45.
  101. Finley EP, Schneegans S, Tami C, Pugh MJ, McGeary D, Penney L, Sharpe Potter J. Implementing prescription drug monitoring and other clinical decision support for opioid risk mitigation in a military health care setting: a qualitative feasibility study. Journal of the American Medical Informatics Association : JAMIA. 2018 May 1; 25(5):515-522.
  102. Humphreys K. How Medicaid Can Strengthen the National Response to the Opioid Epidemic. American journal of public health. 2018 May 1; 108(5):589-590.
  103. Lovejoy TI, Morasco BJ, Demidenko MI, Meath THA, Dobscha SK. Clinician Referrals for Non-opioid Pain Care Following Discontinuation of Long-term Opioid Therapy Differ Based on Reasons for Discontinuation. Journal of general internal medicine. 2018 May 1; 33(Suppl 1):24-30.
  104. Lozier CC, Nugent SM, Smith NX, Yarborough BJ, Dobscha SK, Deyo RA, Morasco BJ. Correlates of Use and Perceived Effectiveness of Non-pharmacologic Strategies for Chronic Pain Among Patients Prescribed Long-term Opioid Therapy. Journal of general internal medicine. 2018 May 1; 33(Suppl 1):46-53.
  105. Quinn PD, Hur K, Chang Z, Scott EL, Krebs EE, Bair MJ, Rickert ME, Gibbons RD, Kroenke K, D'Onofrio BM. Association of Mental Health Conditions and Treatments With Long-term Opioid Analgesic Receipt Among Adolescents. JAMA pediatrics. 2018 May 1; 172(5):423-430.
  106. Matthias MS, Donaldson MT, Jensen AC, Krebs EE. "I Was a Little Surprised": Qualitative Insights From Patients Enrolled in a 12-Month Trial Comparing Opioids With Nonopioid Medications for Chronic Musculoskeletal Pain. The journal of pain : official journal of the American Pain Society. 2018 Sep 1; 19(9):1082-1090.
  107. Adams MH, Dobscha SK, Smith NX, Yarborough BJ, Deyo RA, Morasco BJ. Prevalence and Correlates of Low Pain Interference Among Patients With High Pain Intensity Who Are Prescribed Long-Term Opioid Therapy. The journal of pain : official journal of the American Pain Society. 2018 Sep 1; 19(9):1074-1081.
  108. Lovejoy TI, Dobscha SK, Morasco BJ, Smith CL, Meath T, Demidenko M, McPherson S. Changes in pain intensity following discontinuation of long-term opioid therapy. [Abstract]. Annals of behavioral medicine : a publication of the Society of Behavioral Medicine. 2018 Apr 11; 52(1):S165.
  109. Dana R, Azarpazhooh A, Laghapour N, Suda KJ, Okunseri C. Role of Dentists in Prescribing Opioid Analgesics and Antibiotics: An Overview. Dental clinics of North America. 2018 Apr 1; 62(2):279-294.
  110. Delgado MK, Shofer FS, Patel MS, Halpern S, Edwards C, Meisel ZF, Perrone J. Association between Electronic Medical Record Implementation of Default Opioid Prescription Quantities and Prescribing Behavior in Two Emergency Departments. Journal of general internal medicine. 2018 Apr 1; 33(4):409-411.
  111. Hah J, Mackey SC, Schmidt P, McCue R, Humphreys K, Trafton J, Efron B, Clay D, Sharifzadeh Y, Ruchelli G, Goodman S, Huddleston J, Maloney WJ, Dirbas FM, Shrager J, Costouros JG, Curtin C, Carroll I. Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: A Randomized Clinical Trial. JAMA surgery. 2018 Apr 1; 153(4):303-311.
  112. Herzig SJ, Calcaterra SL, Mosher HJ, Ronan MV, Groningen NV, Shek L, Loffredo A, Keller M, Jena AB, Nuckols TK. Safe Opioid Prescribing for Acute Noncancer Pain in Hospitalized Adults: A Systematic Review of Existing Guidelines. Journal of hospital medicine. 2018 Apr 1; 13(4):256-262.
  113. Herzig SJ, Mosher HJ, Calcaterra SL, Jena AB, Nuckols TK. Improving the Safety of Opioid Use for Acute Noncancer Pain in Hospitalized Adults: A Consensus Statement From the Society of Hospital Medicine. Journal of hospital medicine. 2018 Apr 1; 13(4):263-271.
  114. Hudson TJ, Painter JT, Gressler LE, Lu L, Williams JS, Booth BM, Martin BC, Sullivan MD, Edlund MJ. Factors Associated with Opioid Initiation in OEF/OIF/OND Veterans with Traumatic Brain Injury. Pain medicine (Malden, Mass.). 2018 Apr 1; 19(4):774-787.
  115. Mosher HJ, Hofmeyer BA, Hadlandsmyth K, Richardson KK, Lund BC. Predictors of Long-Term Opioid Use After Opioid Initiation at Discharge From Medical and Surgical Hospitalizations. Journal of hospital medicine. 2018 Apr 1; 13(4):243-248.
  116. Mosher HJ, Richardson KK, Lund BC. Sedative Prescriptions Are Common at Opioid Initiation: An Observational Study in the Veterans Health Administration. Pain medicine (Malden, Mass.). 2018 Apr 1; 19(4):788-792.
  117. Raffel KE, Beach LY, Lin J, Berchuck JE, Abram S, Markle E, Patel S. Naloxone Distribution and Training for Patients with High-Risk Opioid Use in a Veterans Affairs Community-Based Primary Care Clinic. The Permanente journal. 2018 Mar 30; 22.
  118. Lembke A, Humphreys K. The Opioid Epidemic as a Watershed Moment for Physician Training in Addiction Medicine. Academic Psychiatry : The Journal of The American Association of Directors of Psychiatric Residency Training and The Association For Academic Psychiatry. 2018 Apr 1; 42(2):269-272.
  119. Becker WC, Mattocks KM, Frank JW, Bair MJ, Jankowski RL, Kerns RD, Painter JT, Fenton BT, Midboe AM, Martino S. Mixed methods formative evaluation of a collaborative care program to decrease risky opioid prescribing and increase non-pharmacologic approaches to pain management. Addictive Behaviors. 2018 Nov 1; 86(1):138-145.
  120. Krebs EE, Gravely A, Nugent S, Jensen AC, DeRonne B, Goldsmith ES, Kroenke K, Bair MJ, Noorbaloochi S. Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial. JAMA. 2018 Mar 6; 319(9):872-882.
  121. Frakt AB. Overshadowed by the Opioid Crisis: A Comeback by Cocaine. The New York Times. 2018 Mar 5: The Upshot: A3.
  122. Fassio V, Aspinall SL, Zhao X, Miller DR, Singh JA, Good CB, Cunningham FE. Trends in opioid and nonsteroidal anti-inflammatory use and adverse events. The American journal of managed care. 2018 Mar 1; 24(3):e61-e72.
  123. Gressler LE, Martin BC, Hudson TJ, Painter JT. Relationship between concomitant benzodiazepine-opioid use and adverse outcomes among US veterans. Pain. 2018 Mar 1; 159(3):451-459.
  124. Hayes CJ, Ortiz H, Martin B, Hudson TJ, Robertson D, Aram J, Smith GR. Opioid prescribing in Arkansas and next steps. The Journal of The Arkansas Medical Society. 2018 Mar 1; 114(9):200-202.
  125. Hall W, West R, Marsden J, Humphreys K, Neale J, Petry N. It is premature to expand access to medicinal cannabis in hopes of solving the US opioid crisis. [Editorial]. Addiction (Abingdon, England). 2018 Jun 1; 113(6):987-988.
  126. Malte CA, Berger D, Saxon AJ, Hagedorn HJ, Achtmeyer CE, Mariano AJ, Hawkins EJ. Electronic Medical Record Alert Associated With Reduced Opioid and Benzodiazepine Coprescribing in High-risk Veteran Patients. Medical care. 2018 Feb 1; 56(2):171-178.
  127. Nee J, Zakari M, Sugarman MA, Whelan J, Hirsch W, Sultan S, Ballou S, Iturrino J, Lembo A. Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2018 Oct 1; 16(10):1569-1584.e2.
  128. Hadlandsmyth K, Mosher H, Vander Weg MW, Lund BC. Decline in Prescription Opioids Attributable to Decreases in Long-Term Use: A Retrospective Study in the Veterans Health Administration 2010-2016. Journal of general internal medicine. 2018 Jun 1; 33(6):818-824.
  129. Humphreys K. A public health approach to opioid addiction in North America - Author's reply. [Letter to the Editor]. Lancet (London, England). 2018 Jan 20; 391(10117):202.
  130. Argoff CE, Alford DP, Fudin J, Adler JA, Bair MJ, Dart RC, Gandolfi R, McCarberg BH, Stanos SP, Gudin JA, Polomano RC, Webster LR. Rational Urine Drug Monitoring in Patients Receiving Opioids for Chronic Pain: Consensus Recommendations. Pain medicine (Malden, Mass.). 2018 Jan 1; 19(1):97-117.
  131. Wyse JJ, Gordon AJ, Dobscha SK, Morasco BJ, Tiffany E, Drexler K, Sandbrink F, Lovejoy TI. Medications for opioid use disorder in the Department of Veterans Affairs (VA) health care system: Historical perspective, lessons learned, and next steps. Substance Abuse. 2018 Jan 1; 39(2):139-144.
  132. Gellad WF, Thorpe JM, Zhao X, Thorpe CT, Sileanu FE, Cashy JP, Hale JA, Mor MK, Radomski TR, Hausmann LRM, Donohue JM, Gordon AJ, Suda KJ, Stroupe KT, Hanlon JT, Cunningham FE, Good CB, Fine MJ. Impact of Dual Use of Department of Veterans Affairs and Medicare Part D Drug Benefits on Potentially Unsafe Opioid Use. American journal of public health. 2018 Feb 1; 108(2):248-255.
  133. Abraham AJ, Andrews CM, Grogan CM, Pollack HA, D'Aunno T, Humphreys K, Friedmann PD. State-Targeted Funding and Technical Assistance to Increase Access to Medication Treatment for Opioid Use Disorder. Psychiatric services (Washington, D.C.). 2018 Apr 1; 69(4):448-455.
  134. Mosher H, Herzig SJ, Danovitch I, Boutsicaris C, Hassamal S, Wittnebel K, Dashti A, Nuckols T. The Evaluation of Medical Inpatients Who Are Admitted on Long-term Opioid Therapy for Chronic Pain. Journal of hospital medicine. 2018 Apr 1; 13(4):249-255.
  135. Tessier CD. Using Opioids Safely After Surgery. Consumer Reports (Choosing Wisely) [Internet]. 2017 Dec 1: Available from: http://www.choosingwisely.org/wp-content/uploads/2018/02/Using-Opioids-Safely-After-Surgery-AUA.pdf.
  136. Frakt AB. Where Is the Prevention in the President's Opioid Report? The New York Times. 2017 Nov 13: The Upshot: A3.
  137. Nugent SM, Yarborough BJ, Smith NX, Dobscha SK, Deyo RA, Green CA, Morasco BJ. Patterns and correlates of medical cannabis use for pain among patients prescribed long-term opioid therapy. General hospital psychiatry. 2018 Jan 1; 50:104-110.
  138. Giannitrapani KF, Ahluwalia SC, McCaa M, Pisciotta M, Dobscha S, Lorenz KA. Barriers to Using Nonpharmacologic Approaches and Reducing Opioid Use in Primary Care. Pain medicine (Malden, Mass.). 2017 Oct 20.
  139. Tedesco D, Gori D, Desai KR, Asch S, Carroll IR, Curtin C, McDonald KM, Fantini MP, Hernandez-Boussard T. Drug-Free Interventions to Reduce Pain or Opioid Consumption After Total Knee Arthroplasty: A Systematic Review and Meta-analysis. JAMA surgery. 2017 Oct 18; 152(10):e172872.
  140. Lagisetty P, Klasa K, Bush C, Heisler M, Chopra V, Bohnert A. Primary care models for treating opioid use disorders: What actually works? A systematic review. PLoS ONE. 2017 Oct 17; 12(10):e0186315.
  141. Balbale SN, Trivedi I, O'Dwyer LC, McHugh MC, Evans CT, Jordan N, Keefer LA. Strategies to Identify and Reduce Opioid Misuse Among Patients with Gastrointestinal Disorders: A Systematic Scoping Review. Digestive diseases and sciences. 2017 Oct 1; 62(10):2668-2685.
  142. Tedesco D, Asch SM, Curtin C, Hah J, McDonald KM, Fantini MP, Hernandez-Boussard T. Opioid Abuse And Poisoning: Trends In Inpatient And Emergency Department Discharges. Health affairs (Project Hope). 2017 Oct 1; 36(10):1748-1753.
  143. Lovejoy TI, Morasco BJ, Kumthekar A, Shull S, Chang M, Barton J. Eradication of hepatitis C among US veterans: examination of changes in pain severity and prescription opioid use following treatment. [Abstract]. Arthritis + Rheuma.. 2017 Sep 27; 69(10):2221.
  144. Taylor SL. Addressing America's Opioid Problem: The Need for Evidence-Based Strategies: Briefing before the Senator and Congressional staffers, organized by PCORI and Anthem Blue Cross; 2017 Sep 19; Wash DC.
  145. Frakt AB. A Helpful Tool to Combat the Opioid Crisis. New York Times. 2017 Sep 11: The Upshot: The New Health Care.
  146. Gerlach LB, Olfson M, Kales HC, Maust DT. Opioids and Other Central Nervous System-Active Polypharmacy in Older Adults in the United States. Journal of the American Geriatrics Society. 2017 Sep 1; 65(9):2052-2056.
  147. Hadlandsmyth K, Vander Weg MW, McCoy KD, Mosher HJ, Vaughan-Sarrazin MS, Lund BC. Risk for Prolonged Opioid Use Following Total Knee Arthroplasty in Veterans. Journal of Arthroplasty. 2018 Jan 1; 33(1):119-123.
  148. Han L, Allore H, Goulet J, Bathulapali H, Skanderson M, Brandt C, Haskell S, Krebs E. Opioid dosing trends over eight years among US Veterans with musculoskeletal disorders after returning from service in support of recent conflicts. Annals of epidemiology. 2017 Sep 1; 27(9):563-569.e3.
  149. Mosher H, Zhou Y, Thurman AL, Sarrazin MV, Ohl ME. Trends in Hospitalization for Opioid Overdose among Rural Compared to Urban Residents of the United States, 2007-2014. Journal of hospital medicine. 2017 Nov 1; 12(11):925-929.
  150. Frazier W, Cochran G, Lo-Ciganic WH, Gellad WF, Gordon AJ, Chang CH, Donohue JM. Medication-Assisted Treatment and Opioid Use Before and After Overdose in Pennsylvania Medicaid. [Letter to the Editor]. JAMA : the journal of the American Medical Association. 2017 Aug 22; 318(8):750-752.
  151. Frank JW, Lovejoy TI, Becker WC, Morasco BJ, Koenig CJ, Hoffecker L, Dischinger HR, Dobscha SK, Krebs EE. Patient Outcomes in Dose Reduction or Discontinuation of Long-Term Opioid Therapy: A Systematic Review. Annals of internal medicine. 2017 Aug 1; 167(3):181-191.
  152. Ecker AH, Hundt N. Posttraumatic stress disorder in opioid agonist therapy: A review. Psychological trauma : theory, research, practice and policy. 2018 Nov 1; 10(6):636-642.
  153. Humphreys K. Avoiding globalisation of the prescription opioid epidemic. Lancet. 2017 Jul 29; 390(10093):437-439.
  154. Becker W, Lovejoy TI. Opioid dose reduction in patients prescribed long-term opioid therapy for chronic pain. HSR&D Career Development Award Enhancement Initiative [Cyberseminar]. VA HSR&D. 2017 Jul 26.
  155. Becker WC, Lovejoy T. Opioid Dose Reduction in Patients Prescribed Long-Term Opioid Therapy for Chronic Pain. Career Development Award Series [Cyberseminar]. HSR&D. 2017 Jul 26.
  156. Hanks D, Hecht MI, Auffrey RR, Hawkins EJ. Podcast-10: Live from the Meeting: Opioid Co-Prescribing and PTSD Mortality. 2017 Jul 20. 1 (10). Available from: https://www.hsrd.research.va.gov/news/podcasts/default.cfm.
  157. Lagisetty P, Bohnert A. Web Exclusives. Annals for Hospitalists Inpatient Notes - The Opioid Epidemic-What's a Hospitalist to Do?. Annals of internal medicine. 2017 Jul 18; 167(2):HO2-HO3.
  158. Cochran G, McCarthy R, Gordon AJ, Tarter RE. Opioid medication misuse among unhealthy drinkers. Drug and Alcohol Dependence. 2017 Oct 1; 179:13-17.
  159. Midboe AM. Best practices for Academic Detailing for Opioid Prescribing: Briefing before the National CMO Chief of Staff; 2017 Jul 10; Teleconference.
  160. Matthias MS, Johnson NL, Shields CG, Bair MJ, MacKie P, Huffman M, Alexander SC. "I'm Not Gonna Pull the Rug out From Under You": Patient-Provider Communication About Opioid Tapering. The journal of pain : official journal of the American Pain Society. 2017 Nov 1; 18(11):1365-1373.
  161. Becker WC, Fenton BT, Brandt CA, Doyle EL, Francis J, Goulet JL, Moore BA, Torrise V, Kerns RD, Kreiner PW. Multiple Sources of Prescription Payment and Risky Opioid Therapy Among Veterans. Medical care. 2017 Jul 1; 55 Suppl 7 Suppl 1:S33-S36.
  162. Lovejoy TI. Discontinuation of Long-Term Opioid Therapy among Veterans is Overwhelmingly Initiated by VA Clinicians. 2017 Jul 1.
  163. Watkins KE, Paddock SM, Hudson TJ, Ounpraseuth S, Schrader AM, Hepner KA, Stein BD. Association between process measures and mortality in individuals with opioid use disorders. Drug and Alcohol Dependence. 2017 Aug 1; 177:307-314.
  164. Brummett CM, Waljee JF, Goesling J, Moser S, Lin P, Englesbe MJ, Bohnert ASB, Kheterpal S, Nallamothu BK. New Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults. JAMA surgery. 2017 Jun 21; 152(6):e170504.
  165. Kroenke K, Cheville A. Management of Chronic Pain in the Aftermath of the Opioid Backlash. JAMA. 2017 Jun 20; 317(23):2365-2366.
  166. Mundkur ML, Gordon AJ, Kertesz SG. Will strict limits on opioid prescription duration prevent addiction? Advocating for evidence-based policymaking. Substance Abuse. 2017 Jul 1; 38(3):237-238.
  167. Banerjee G, Edelman EJ, Barry DT, Becker WC, Cerdá M, Crystal S, Gaither JR, Gordon AJ, Gordon KS, Kerns RD, Martins SS, Fiellin DA, Marshall BDL. Reply to Osborne & Serdarevic (2017): Potential impact of exposure definition when examining non-medical use of prescription opioids among US veterans. [Letter to the Editor]. Addiction (Abingdon, England). 2017 Aug 1; 112(8):1510-1511.
  168. Nugent SM, Dobscha SK, Morasco BJ, Demidenko MI, Meath THA, Frank JW, Lovejoy TI. Substance Use Disorder Treatment Following Clinician-Initiated Discontinuation of Long-Term Opioid Therapy Resulting from an Aberrant Urine Drug Test. Journal of general internal medicine. 2017 Oct 1; 32(10):1076-1082.
  169. Bastian LA, Driscoll MA, Heapy AA, Becker WC, Goulet JL, Kerns RD, DeRycke EC, Perez E, Lynch SM, Mattocks K, Kroll-Desrosiers AR, Brandt CA, Skanderson M, Bathulapalli H, Haskell SG. Cigarette Smoking Status and Receipt of an Opioid Prescription Among Veterans of Recent Wars. Pain medicine (Malden, Mass.). 2017 Jun 1; 18(6):1089-1097.
  170. Becker WC, Fiellin DA. Abuse-Deterrent Opioid Formulations - Putting the Potential Benefits into Perspective. [Editorial]. The New England journal of medicine. 2017 Jun 1; 376(22):2103-2105.
  171. Hudson TJ, Painter JT, Martin BC, Austen MA, Williams JS, Fortney JC, Sullivan MD, Edlund MJ. Pharmacoepidemiologic analyses of opioid use among OEF/OIF/OND veterans. Pain. 2017 Jun 1; 158(6):1039-1045.
  172. Cochran G, Rosen D, McCarthy RM, Engel RJ. Risk Factors for Symptoms of Prescription Opioid Misuse: Do Older Adults Differ from Younger Adult Patients?. Journal of gerontological social work. 2017 Aug 1; 60(6-7):443-457.
  173. Busse JW, Craigie S, Juurlink DN, Buckley DN, Wang L, Couban RJ, Agoritsas T, Akl EA, Carrasco-Labra A, Cooper L, Cull C, da Costa BR, Frank JW, Grant G, Iorio A, Persaud N, Stern S, Tugwell P, Vandvik PO, Guyatt GH. Guideline for opioid therapy and chronic noncancer pain. CMAJ: Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 2017 May 8; 189(18):E659-E666.
  174. Midboe AM. Academic Detailing for Opioid Prescribing in VISN 21:Results from a Qualitative Rapid Analysis: Briefing before the National Pharmacy Benefits Management Advisory Board; 2017 May 2; San Diego, CA.
  175. Bossi KE. HSR&D e-Pub Briefs-3: Summaries of select journal articles published by HSR&D investigators on Acute Pain, Chronic Pain, C. Diff Infection, Hypertension, and Opioids. 2017 May 1; 9(3).
  176. Cochran G, Gordon AJ, Gellad WF, Chang CH, Lo-Ciganic WH, Lobo C, Cole E, Frazier W, Zheng P, Kelley D, Donohue JM. Medicaid prior authorization and opioid medication abuse and overdose. The American journal of managed care. 2017 May 1; 23(5):e164-e171.
  177. Gellad WF, Good CB, Shulkin DJ. Addressing the Opioid Epidemic in the United States: Lessons From the Department of Veterans Affairs. [Editorial]. JAMA internal medicine. 2017 May 1; 177(5):611-612.
  178. Lin LA, Bohnert ASB, Kerns RD, Clay MA, Ganoczy D, Ilgen MA. Impact of the Opioid Safety Initiative on opioid-related prescribing in veterans. Pain. 2017 May 1; 158(5):833-839.
  179. Demidenko MI, Dobscha SK, Morasco BJ, Meath THA, Ilgen MA, Lovejoy TI. Suicidal ideation and suicidal self-directed violence following clinician-initiated prescription opioid discontinuation among long-term opioid users. General hospital psychiatry. 2017 Jul 1; 47:29-35.
  180. Suda KJ, Smith BM, Bailey L, Gellad WF, Huo Z, Burk M, Cunningham F, Stroupe KT. Opioid dispensing and overlap in veterans with non-cancer pain eligible for Medicare Part D. Journal of the American Pharmacists Association : JAPhA. 2017 May 1; 57(3):333-340.e3.
  181. Becker WC, Gordon K, Edelman EJ, Kerns RD, Crystal S, Dziura JD, Fiellin LE, Gordon AJ, Goulet JL, Justice AC, Fiellin DA. Erratum to: Trends in Any and High-Dose Opioid Analgesic Receipt Among Aging Patients With and Without HIV. AIDS and behavior. 2017 Apr 1; 21(4):1228.
  182. Gordon AJ, Harding JD. From education to practice: Addressing opioid misuse through health care provider training: A special issue of Substance Abuse journal. Substance Abuse. 2017 Apr 1; 38(2):119-121.
  183. Lovejoy TI, Demidenko MI, Morasco BJ, Meath T, Dobscha SK. Suicidal ideation and behaviors following clinician-initiated prescription opioid discontinuation among long-term opioid users. [Abstract]. The journal of pain : official journal of the American Pain Society. 2017 Apr 1; 18(4):S36.
  184. Morasco BJ, Yarborough BJ, Smith NX, Dobscha SK, Deyo RA, Perrin NA, Green CA. Higher Prescription Opioid Dose is Associated With Worse Patient-Reported Pain Outcomes and More Health Care Utilization. The journal of pain : official journal of the American Pain Society. 2017 Apr 1; 18(4):437-445.
  185. Winograd RP, Davis CS, Niculete M, Oliva E, Martielli RP. Medical providers' knowledge and concerns about opioid overdose education and take-home naloxone rescue kits within Veterans Affairs health care medical treatment settings. Substance Abuse. 2017 Apr 1; 38(2):135-140.
  186. Sun EC, Dixit A, Humphreys K, Darnall BD, Baker LC, Mackey S. Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis. BMJ (Clinical research ed.). 2017 Mar 14; 356:j760.
  187. Friedmann PD, Andrews CM, Humphreys K. How ACA Repeal Would Worsen the Opioid Epidemic. The New England journal of medicine. 2017 Mar 9; 376(10):e16.
  188. Hawkins EJ, Malte CA, Hagedorn HJ, Berger D, Frank A, Lott A, Achtmeyer CE, Mariano AJ, Saxon AJ. Survey of Primary Care and Mental Health Prescribers' Perspectives on Reducing Opioid and Benzodiazepine Co-Prescribing Among Veterans. Pain medicine (Malden, Mass.). 2017 Mar 1; 18(3):454-467.
  189. Hayes CJ, Painter JT. A comprehensive clinical review of opioid-induced allodynia: Discussion of the current evidence and clinical implications. Journal of opioid management. 2017 Mar 1; 13(2):95-103.
  190. Lovejoy TI, Morasco BJ, Demidenko MI, Meath TH, Frank JW, Dobscha SK. Reasons for discontinuation of long-term opioid therapy in patients with and without substance use disorders. Pain. 2017 Mar 1; 158(3):526-534.
  191. Oliva EM, Christopher ML, Wells D, Bounthavong M, Harvey M, Himstreet J, Emmendorfer T, Valentino M, Franchi M, Goodman F, Trafton JA, Veterans Health Administration Opioid Overdose Education and Naloxone Distribution National Support and Development Workgroup. Opioid overdose education and naloxone distribution: Development of the Veterans Health Administration's national program. Journal of the American Pharmacists Association : JAPhA. 2017 Mar 1; 57(2S):S168-S179.e4.
  192. Hanks D. QUERI e-News-1: Pain Management and Opioid Use. [Newsletter] 2017 Feb 28. 9 (1). Available from: https://www.queri.research.va.gov/qnews/feb17/default.cfm.
  193. Krebs E, Urada D, Evans E, Huang D, Hser YI, Nosyk B. The costs of crime during and after publicly funded treatment for opioid use disorders: a population-level study for the state of California. Addiction (Abingdon, England). 2017 May 1; 112(5):838-851.
  194. Frakt AB. Assessing and Reducing Opioid Prescription Risk: VA Response to the Comprehensive Addiction and Recovery Act of 2016. QUERI eNews. 2017 Feb 3; Feb 2017(1): 1.
  195. Oliva EM, Bowe T, Tavakoli S, Martins S, Lewis ET, Paik M, Wiechers I, Henderson P, Harvey M, Avoundjian T, Medhanie A, Trafton JA. Development and applications of the Veterans Health Administration's Stratification Tool for Opioid Risk Mitigation (STORM) to improve opioid safety and prevent overdose and suicide. Psychological Services. 2017 Feb 1; 14(1):34-49.
  196. Banerjee G, Edelman EJ, Barry DT, Becker WC, Cerdá M, Crystal S, Gaither JR, Gordon AJ, Gordon KS, Kerns RD, Martins SS, Fiellin DA, Marshall BD. Reply to Ruan et al. (2017): Non-medical use of prescription opioids is associated with heroin initiation among US veterans. [Letter to the Editor]. Addiction (Abingdon, England). 2017 Apr 1; 112(4):728-729.
  197. Guillod P, Edens EL, Becker WC. Ultra-High-Dose Opioids With Low Efficacy and Significant Harm-Time to Make a Change: A Teachable Moment. [Editorial]. JAMA internal medicine. 2017 Jan 1; 177(1):17-18.
  198. Quinn PD, Hur K, Chang Z, Krebs EE, Bair MJ, Scott EL, Rickert ME, Gibbons RD, Kroenke K, D'Onofrio BM. Incident and long-term opioid therapy among patients with psychiatric conditions and medications: a national study of commercial health care claims. Pain. 2017 Jan 1; 158(1):140-148.
  199. Stein BD, Mendelsohn J, Gordon AJ, Dick AW, Burns RM, Sorbero M, Shih RA, Liccardo Pacula R. Opioid analgesic and benzodiazepine prescribing among Medicaid-enrollees with opioid use disorders: The influence of provider communities. Journal of addictive diseases. 2017 Jan 1; 36(1):14-22.
  200. Krebs E, Min JE, Evans E, Li L, Liu L, Huang D, Urada D, Kerr T, Hser YI, Nosyk B. Estimating State Transitions for Opioid Use Disorders. Medical Decision Making. 2017 Jul 1; 37(5):483-497.
  201. Sigmon SC, Ochalek TA, Meyer AC, Hruska B, Heil SH, Badger GJ, Rose G, Brooklyn JR, Schwartz RP, Moore BA, Higgins ST. Interim Buprenorphine vs. Waiting List for Opioid Dependence. [Letter to the Editor]. The New England journal of medicine. 2016 Dec 22; 375(25):2504-2505.
  202. Gellad WF, Zhao X, Thorpe CT, Thorpe JM, Sileanu FE, Cashy JP, Mor M, Hale JA, Radomski T, Hausmann LR, Fine MJ, Good CB. Overlapping buprenorphine, opioid, and benzodiazepine prescriptions among veterans dually enrolled in Department of Veterans Affairs and Medicare Part D. Substance Abuse. 2017 Jan 1; 38(1):22-25.
  203. Brennan PL, Del Re AC, Henderson PT, Trafton JA. Healthcare system-wide implementation of opioid-safety guideline recommendations: the case of urine drug screening and opioid-patient suicide- and overdose-related events in the Veterans Health Administration. Translational behavioral medicine. 2016 Dec 1; 6(4):605-612.
  204. Ducoffe AR, York A, Hu DJ, Perfetto D, Kerns RD. National Action Plan for Adverse Drug Event Prevention: Recommendations for Safer Outpatient Opioid Use. Pain medicine (Malden, Mass.). 2016 Dec 1; 17(12):2291-2304.
  205. Grogan CM, Andrews C, Abraham A, Humphreys K, Pollack HA, Smith BT, Friedmann PD. Survey Highlights Differences In Medicaid Coverage For Substance Use Treatment And Opioid Use Disorder Medications. Health affairs (Project Hope). 2016 Dec 1; 35(12):2289-2296.
  206. Moore BA, Fiellin DA, Cutter CJ, Buono FD, Barry DT, Fiellin LE, O'Connor PG, Schottenfeld RS. Cognitive Behavioral Therapy Improves Treatment Outcomes for Prescription Opioid Users in Primary Care Buprenorphine Treatment. Journal of substance abuse treatment. 2016 Dec 1; 71:54-57.
  207. Banerjee G, Edelman EJ, Barry DT, Becker WC, Cerdá M, Crystal S, Gaither JR, Gordon AJ, Gordon KS, Kerns RD, Martins SS, Fiellin DA, Marshall BD. Non-medical use of prescription opioids is associated with heroin initiation among US veterans: a prospective cohort study. Addiction (Abingdon, England). 2016 Nov 1; 111(11):2021-2031.
  208. Bastian LA. Cigarette Smoking as a Risk Factor for Chronic Opioid Use. Spotlight on Pain Management [Cyberseminar]. 2016 Nov 1.
  209. Bossi KE. HSR&D e-Pub Briefs-1: Summaries of select journal articles published by HSR&D investigators on Hepatitis C, Opioids, Surgery, Bipolar Disorder, and Obesity. 2016 Nov 1; 9(1).
  210. Choo EK, Feldstein Ewing SW, Lovejoy TI. Opioids Out, Cannabis In: Negotiating the Unknowns in Patient Care for Chronic Pain. JAMA. 2016 Nov 1; 316(17):1763-1764.
  211. Edelman EJ, Gordon KS, Tate JP, Becker WC, Bryant K, Crothers K, Gaither JR, Gibert CL, Gordon AJ, Marshall B, Rodriguez-Barradas MC, Samet JH, Skanderson M, Justice AC, Fiellin DA. The impact of prescribed opioids on CD4 cell count recovery among HIV-infected patients newly initiating antiretroviral therapy. HIV Medicine. 2016 Nov 1; 17(10):728-739.
  212. Gaither JR, Goulet JL, Becker WC, Crystal S, Edelman EJ, Gordon K, Kerns RD, Rimland D, Skanderson M, Justice AC, Fiellin DA. The Effect of Substance Use Disorders on the Association Between Guideline-concordant Long-term Opioid Therapy and All-cause Mortality. Journal of addiction medicine. 2016 Nov 1; 10(6):418-428.
  213. Lin LA, Hosanagar A, Park TW, Bohnert AS. Opioid Overdose: Risk Assessment and Mitigation in Outpatient Treatment. Journal of addiction medicine. 2016 Nov 1; 10(6):382-386.
  214. Naples JG, Gellad WF, Hanlon JT. The Role of Opioid Analgesics in Geriatric Pain Management. Clinics in geriatric medicine. 2016 Nov 1; 32(4):725-735.
  215. Roberts AW, Gellad WF, Skinner AC. Lock-In Programs and the Opioid Epidemic: A Call for Evidence. [Editorial]. American journal of public health. 2016 Nov 1; 106(11):1918-1919.
  216. White W, Galanter M, Humphreys KN, Kelly JF. The Paucity of Attention to Narcotics Anonymous in Current Public, Professional, and Policy Responses to Rising Opioid Addiction. Alcoholism Treatment Quarterly. 2016 Oct 5; 34(4):437-462.
  217. Frank JW, Levy C, Matlock DD, Calcaterra SL, Mueller SR, Koester S, Binswanger IA. Patients' Perspectives on Tapering of Chronic Opioid Therapy: A Qualitative Study. Pain medicine (Malden, Mass.). 2016 Oct 1; 17(10):1838-1847.
  218. Henry SG, Chen M, Matthias MS, Bell RA, Kravitz RL. Development of the Chronic Pain Coding System (CPCS) for Characterizing Patient-Clinician Discussions About Chronic Pain and Opioids. Pain medicine (Malden, Mass.). 2016 Oct 1; 17(10):1892-1905.
  219. Rogal S, Mankaney G, Udawatta V, Good CB, Chinman M, Zickmund S, Bielefeldt K, Jonassaint N, Jazwinski A, Shaikh O, Hughes C, Humar A, DiMartini A, Fine MJ. Association between opioid use and readmission following liver transplantation. Clinical Transplantation. 2016 Oct 1; 30(10):1222-1229.
  220. Midboe AM. Academic Detailing for Opioid Prescribing in VISN 21: Results from a Qualitative Rapid Analysis. Presented at: VA Academic Detailing Leadership Training Meeting; 2016 Sep 21; San Diego, CA.
  221. Stein BD, Sorbero M, Dick AW, Pacula RL, Burns RM, Gordon AJ. Physician Capacity to Treat Opioid Use Disorder With Buprenorphine-Assisted Treatment. JAMA. 2016 Sep 20; 316(11):1211-1212.
  222. Lembke A, Chen JH. Use of Opioid Agonist Therapy for Medicare Patients in 2013. JAMA psychiatry. 2016 Sep 1; 73(9):990-2.
  223. Seal KH, Maguen S, Bertenthal D, Batki SL, Striebel J, Stein MB, Madden E, Neylan TC. Observational Evidence for Buprenorphine's Impact on Posttraumatic Stress Symptoms in Veterans With Chronic Pain and Opioid Use Disorder. The Journal of clinical psychiatry. 2016 Sep 1; 77(9):1182-1188.
  224. Tetrault JM, Tate JP, Edelman EJ, Gordon AJ, Lo Re V, Lim JK, Rimland D, Goulet J, Crystal S, Gaither JR, Gibert CL, Rodriguez-Barradas MC, Fiellin LE, Bryant K, Justice AC, Fiellin DA. Hepatic Safety of Buprenorphine in HIV-Infected and Uninfected Patients With Opioid Use Disorder: The Role of HCV-Infection. Journal of substance abuse treatment. 2016 Sep 1; 68:62-7.
  225. Midboe AM. Academic Detailing for Opioid Prescribing in VISN 21: Translating Lessons Learned. Presented at: VA Center for Innovation to Implementation (Ci2i) Annual Steering Committee Meeting; 2016 Aug 30; Menlo Park, CA.
  226. Lagisetty P, Heisler M, Bohnert A. Re-purposing anticoagulation clinics: expanding access to opioid agonist therapy in primary care settings. Addiction (Abingdon, England). 2017 Mar 1; 112(3):384-385.
  227. Midboe AM. Academic Detailing for Opioid Prescribing in VISN 21: Results from a Qualitative Rapid Analysis: Briefing before the National Pharmacy Benefits Management (PBM); 2016 Aug 23; Teleconference.
  228. Gellad WF. University of Pittsburgh Efforts to Address the Opioid Epidemic: Briefing before the Assistant Secretary for Financial Resources, United States Department of Health and Human Services; 2016 Aug 9; Pittsburgh, PA.
  229. Hanks D. In Progress-2: Improving the Safety of Prescription Opioid Use among Veterans. 2016 Aug 3; 1(2).
  230. Chen JH, Hom J, Richman I, Asch SM, Podchiyska T, Johansen NA. Effect of opioid prescribing guidelines in primary care. Medicine. 2016 Aug 1; 95(35):e4760.
  231. Tobin DG, Andrews R, Becker WC. In Reply: Prescribing opioids. Cleveland Clinic journal of medicine. 2016 Aug 1; 83(8):554-5.
  232. Heapy AA, Becker WC, Midboe AM. Improving Opioid Therapy among Veterans with Chronic Pain. In Progress. 2016 Jul 29; 2016(2): http://www.hsrd.research.va.gov/publications/inprogress/jul16/default.cfm?InProgressMenu=jul16-1.
  233. Barry DT, Sofuoglu M, Kerns RD, Wiechers IR, Rosenheck RA. Prevalence and correlates of coprescribing anxiolytic medications with extensive prescription opioid use in Veterans Health Administration patients with metastatic cancer. Journal of opioid management. 2016 Jul 1; 12(4):259-68.
  234. Becker WC, Tetrault JM. Medical Marijuana in Patients Prescribed Opioids: A Cloud of Uncertainty. Mayo Clinic proceedings. 2016 Jul 1; 91(7):830-2.
  235. Bedson J, Chen Y, Hayward RA, Ashworth J, Walters K, Dunn KM, Jordan KP. Trends in long-term opioid prescribing in primary care patients with musculoskeletal conditions: an observational database study. Pain. 2016 Jul 1; 157(7):1525-31.
  236. Gordon AJ, Saba SK. Confronting the opioid epidemic through publication, promotion, and dissemination of evidence-based addiction scholarship. [Editorial]. Substance Abuse. 2016 Jul 1; 37(3):379-380.
  237. Lembke A, Humphreys K, Newmark J. Weighing the Risks and Benefits of Chronic Opioid Therapy. American Family Physician. 2016 Jun 15; 93(12):982-90.
  238. Krebs EE. ACP representative to the AMA Task Force to reduce Opioid Abuse and spoke on a panel at the AMA Delegates meeting. What practical tools exist-or are needed-to help physicians better manage patients with chronic non-cancer pain? Presented at: American Medical Association Annual Meeting; 2016 Jun 13; Chicago, IL.
  239. Bohnert AS, Bonar EE, Cunningham R, Greenwald MK, Thomas L, Chermack S, Blow FC, Walton M. A pilot randomized clinical trial of an intervention to reduce overdose risk behaviors among emergency department patients at risk for prescription opioid overdose. Drug and Alcohol Dependence. 2016 Jun 1; 163:40-7.
  240. Gellad WF. Opioids and Dual Healthcare System Use. HSR&D Forum. 2016 May 31.
  241. Saver JA, Zhao X, Jing T, Abotsi EJ, Thorpe JM, Thorpe CT, Skledar S. Use of Performance Measures to Quantify Opioid Misuse Risks. Poster session presented at: Pharmacy Quality Alliance Annual Meeting and Innovation Forum; 2016 May 18; Arlington, VA.
  242. Burgess DJ, Nelson DB, Gravely AA, Bair MJ, kerns RD, Higgins D. Healthcare system level factors: Racial differences in prescription of opioid analgesics for chronic non-cancer pain. Presented at: American Academy of Pain Medicine Annual Meeting; 2016 May 12; Austin, TX.
  243. Burgess DJ, Nelson DB, Gravely AA, Bair MJ, Kerns RD, Higgins D, Van Ryn M, Farmer Coste MM. Healthcare system level factors: Racial differences in prescription of opioid analgesics for chronic non-cancer pain. Paper presented at: American Pain Society Annual Meeting; 2016 May 12; Austin, TX.
  244. Frank JW, Lovejoy TI, Becker W, Morasco BJ, Koenig CJ, Dischinger HR, Dobscha SK, Krebs EE. Dose Reduction and Discontinuation of Long-Term Opioid Therapy: A Systematic Review. Paper presented at: Society of General Internal Medicine Annual Meeting; 2016 May 11; Hollywood, FL.
  245. Mosher HJ, Richardson KK, Lund BC. The One Year Treatment Course of New Opioid Recipients in Veterans Health Administration. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2016 May 11; Hollywood, FL.
  246. Robbins JL, McGinnis KA, Edelman EJ, Gordon AJ, Manhapra A, Fiellin DA, Moore BA, Korthuis PT, Gaither JR, Gordon KS, Barry D, Crystal S, Justice AC, Kraemer K. Predictors of Initiating Opioid Agonist Therapy in a Large US Cohort of HIV-Infected and Uninfected Patients. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2016 May 11; Hollywood, FL.
  247. Merlin JS, Young SR, Azari S, Becker WC, Liebschutz JM, Pomeranz J, Roy P, Saini S, Starrels JL, Edelman EJ. Management of problematic behaviours among individuals on long-term opioid therapy: protocol for a Delphi study. BMJ open. 2016 May 6; 6(5):e011619.
  248. Lovejoy TI, Morasco BJ, Demidenko MI, Meath TH, Dobscha SK. Reasons for discontinuation of long-term opioid therapy in patients with and without substance use disorders. Poster session presented at: American Pain Society Annual Meeting; 2016 May 2; Austin, TX.
  249. Bohnert AS, Logan JE, Ganoczy D, Dowell D. A Detailed Exploration Into the Association of Prescribed Opioid Dosage and Overdose Deaths Among Patients With Chronic Pain. Medical care. 2016 May 1; 54(5):435-41.
  250. Calcaterra SL, Yamashita TE, Min SJ, Keniston A, Frank JW, Binswanger IA. Opioid Prescribing at Hospital Discharge Contributes to Chronic Opioid Use. Journal of general internal medicine. 2016 May 1; 31(5):478-85.
  251. Gaither JR, Goulet JL, Becker WC, Crystal S, Edelman EJ, Gordon K, Kerns RD, Rimland D, Skanderson M, Justice AC, Fiellin DA. The Association Between Receipt of Guideline-Concordant Long-Term Opioid Therapy and All-Cause Mortality. Journal of general internal medicine. 2016 May 1; 31(5):492-501.
  252. Ilgen MA, Bohnert AS, Ganoczy D, Bair MJ, McCarthy JF, Blow FC. Opioid dose and risk of suicide. Pain. 2016 May 1; 157(5):1079-84.
  253. Krebs EE, Paudel M, Taylor BC, Bauer DC, Fink HA, Lane NE, Ensrud KE, Osteoporotic Fractures in Men (MrOS) Study Research Group. Association of Opioids with Falls, Fractures, and Physical Performance among Older Men with Persistent Musculoskeletal Pain. Journal of general internal medicine. 2016 May 1; 31(5):463-9.
  254. Matusiewicz AK, Ilgen MA, Bonar EE, Price A, Bohnert AS. The Relationship Between Non-Medical Use of Prescription Opioids and Sex Work Among Adults in Residential Substance Use Treatment. Journal of substance abuse treatment. 2016 May 1; 64:24-8.
  255. Diulio AR, Demidenko MI, Lovejoy TI. Multidisciplinary pain clinics, in Treating comorbid opioid use disorder and dependence in chronic pain. Ed. Matthews, AM. Springer International Publishing, 2016: pp. 177-184. SpringerPlus. 2016 Apr 30.
  256. Becker WC. Rigorous Epidemiologic Work Shows Positive Impact of VHA's Efforts to Rein in Opioid Prescribing. Pain medicine (Malden, Mass.). 2016 Apr 26.
  257. Mosher HJ, Richardson KK, Lund BC. The 1-Year Treatment Course of New Opioid Recipients in Veterans Health Administration. Pain medicine (Malden, Mass.). 2016 Apr 5.
  258. Lovejoy TI, Morasco BJ, Demidenko MI, Meath TH, Frank JW, Dobscha SK. Reasons for discontinuation of long-term opioid therapy in patients with and without substance use disorders. [Abstract]. Pain. 2016 Apr 1; 17(4):s87.
  259. Martin BC, Hayes C, Austen M, Hudson T. Author response to "Impact of survival bias on opioid-related outcomes when using death as an exclusion criterion". [Letter to the Editor]. Pharmacoepidemiology and drug safety. 2016 Apr 1; 25(4):477-8.
  260. Timko C, Gupta S, Schultz N, Harris AH. Veterans' Service Utilization Patterns After Alcohol and Opioid Detoxification in VHA Care. Psychiatric services (Washington, D.C.). 2016 Apr 1; 67(4):460-4.
  261. Finlay AK, Binswanger I, Timko C, Rosenthal J, Clark S, Blue-Howells J, McGuire J, Hagedorn H, Wong J, Van Campen J, Sox-Harris AH. Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients. Drug and Alcohol Dependence. Paper presented at: Academic and Health Policy Conference on Correctional Health; 2016 Mar 18; Baltimore, MD.
  262. Becker WC, Gordon K, Jennifer Edelman E, Kerns RD, Crystal S, Dziura JD, Fiellin LE, Gordon AJ, Goulet JL, Justice AC, Fiellin DA. Trends in Any and High-Dose Opioid Analgesic Receipt Among Aging Patients With and Without HIV. AIDS and behavior. 2016 Mar 1; 20(3):679-86.
  263. Cochran G, Gordon AJ, Field C, Bacci J, Dhital R, Ylioja T, Stitzer M, Kelly T, Tarter R. Developing a framework of care for opioid medication misuse in community pharmacy. Research in social & administrative pharmacy : RSAP. 2016 Mar 1; 12(2):293-301.
  264. Finlay AK, Harris AH, Rosenthal J, Blue-Howells J, Clark S, McGuire J, Timko C, Frayne SM, Smelson D, Oliva E, Binswanger I. Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients. Drug and Alcohol Dependence. 2016 Mar 1; 160:222-6.
  265. Fudalej S, Jakubczyk A, Kopera M, Piwonski J, Bielecki W, Drygas W, Wasilewska K, Ilgen M, Bohnert A, Barry K, Ploski R, Blow FC, Wojnar M. DISC1 as a Possible Genetic Contribution to Opioid Dependence in a Polish Sample. Journal of studies on alcohol and drugs. 2016 Mar 1; 77(2):220-6.
  266. Kroll-Desrosiers AR, Skanderson M, Bastian LA, Brandt CA, Haskell S, Kerns RD, Mattocks KM. Receipt of Prescription Opioids in a National Sample of Pregnant Veterans Receiving Veterans Health Administration Care. Women's health issues : official publication of the Jacobs Institute of Women's Health. 2016 Mar 1; 26(2):240-6.
  267. Tobin DG, Andrews R, Becker WC. Prescribing opioids in primary care: Safely starting, monitoring, and stopping. Cleveland Clinic journal of medicine. 2016 Mar 1; 83(3):207-15.
  268. Krebs EE, Kroenke K, Wu J, Bair MJ, Kozak MA, Yu Z. Opioid Use as a Predictor of Health Care Use and Pain Outcomes: Analysis of Clinical Trial Data. Pain medicine (Malden, Mass.). 2016 Feb 25.
  269. Krebs EE, Gravely AA, Jensen AC, Bair M, Kroenke K. Expectations and analgesic preferences among participants in a 12-month trial comparing opioid versus non-opioid analgesics for chronic pain. Poster session presented at: American Academy of Pain Medicine Annual Meeting; 2016 Feb 20; Palm Springs, CA.
  270. Krebs EE, Kroenke K, Bair MJ, Jensen A. Expectations and Analgesic Preferences Among Participants in a 12-month Trial Comparing Opioid Versus Non-Opioid Analgesics for Chronic Pain. Presented at: American Academy of Pain Medicine Annual Meeting; 2016 Feb 18; Palm Springs, CA.
  271. Ilgen MA. High opioid doses could be marker for suicide risk. VA Research Currents. 2016 Feb 3.
  272. Becker WC, Fiellin DA, Black AC, Kostovich CT, Kerns RD, Fraenkel L. Initial development of patient-reported instrument assessing harm, efficacy, and misuse of long-term opioid therapy. Journal of rehabilitation research and development. 2016 Feb 1; 53(1):127-36.
  273. Burgess DJ, Gravely AA, Nelson DB, Bair MJ, Kerns RD, Higgins DM, Farmer MM, Partin MR. Association between pain outcomes and race and opioid treatment: Retrospective cohort study of Veterans. Journal of rehabilitation research and development. 2016 Feb 1; 53(1):13-24.
  274. Chen JH, Humphreys K, Shah NH, Lembke A. Distribution of Opioids by Different Types of Medicare Prescribers. JAMA internal medicine. 2016 Feb 1; 176(2):259-61.
  275. Krein SL, Bohnert A, Kim HM, Harris ME, Richardson CR. Opioid use and walking among patients with chronic low back pain. Journal of rehabilitation research and development. 2016 Feb 1; 53(1):107-16.
  276. Lovejoy TI, Dobscha SK, Turk DC, Weimer MB, Morasco BJ. Correlates of prescription opioid therapy in Veterans with chronic pain and history of substance use disorder. Journal of rehabilitation research and development. 2016 Feb 1; 53(1):25-36.
  277. Becker WC, Merlin JS, Manhapra A, Edens EL. Management of patients with issues related to opioid safety, efficacy and/or misuse: a case series from an integrated, interdisciplinary clinic. Addiction science & clinical practice. 2016 Jan 28; 11(1):3.
  278. Barry CL, Kennedy-Hendricks A, Gollust SE, Niederdeppe J, Bachhuber MA, Webster DW, McGinty EE. Understanding Americans' views on opioid pain reliever abuse. Addiction (Abingdon, England). 2016 Jan 1; 111(1):85-93.
  279. Binswanger IA, Gordon AJ. From risk reduction to implementation: Addressing the opioid epidemic and continued challenges to our field. [Editorial]. Substance Abuse. 2016 Jan 1; 37(1):1-3.
  280. Oliva EM, Nevedal A, Lewis ET, McCaa MD, Cochran MF, Konicki PE, Davis CS, Wilder C. Patient perspectives on an opioid overdose education and naloxone distribution program in the U.S. Department of Veterans Affairs. Substance Abuse. 2016 Jan 1; 37(1):118-26.
  281. Wright AP, Becker WC, Schiff GD. Strategies for Flipping the Script on Opioid Overprescribing. JAMA internal medicine. 2016 Jan 1; 176(1):7-8.
  282. Fassio V, Aspinall SL, Cunningham J, Zhao X. Trends in Non-Steroidal Anti-Inflammatory Drug Prescriptions Before and After an Opioid Safety Initiative in the Veterans Health Administration. Presented at: American Society of Health-System Pharmacists Midyear Clinical Meeting; 2015 Dec 6; New Orleans, LA.
  283. Krans EE, Zickmund SL, Rustgi VK, Park SY, Dunn SL, Schwarz EB. Screening and evaluation of hepatitis C virus infection in pregnant women on opioid maintenance therapy: A retrospective cohort study. Substance Abuse. 2015 Nov 16; 37(1):88-95.
  284. Burns RM, Pacula RL, Bauhoff S, Gordon AJ, Hendrikson H, Leslie DL, Stein BD. Policies Related To Opioid Agonist Therapy for Opioid Use Disorders: The Evolution of State Policies from 2004 to 2013. Substance Abuse. 2015 Nov 13; 37(1):63-9.
  285. Cochran G, Gordon AJ, Field C, Bacci J, Dhital R, Ylioja T, Stitzer M, Kelly T, Tarter R. A Continuum of Care Model for Opioid Misuse in Community Pharmacy. Paper presented at: Association for Medical Education and Research in Substance Abuse Annual Meeting; 2015 Nov 6; Washington, DC.
  286. Bachhuber MA, Roberts CB, Metraux S, Montgomery AE. Screening for homelessness among individuals initiating medication-assisted treatment for opioid use disorder in the Veterans Health Administration. Journal of opioid management. 2015 Nov 1; 11(6):459-62.
  287. Gordon AJ, Lo-Ciganic WH, Cochran G, Gellad WF, Cathers T, Kelley D, Donohue JM. Patterns and Quality of Buprenorphine Opioid Agonist Treatment in a Large Medicaid Program. Journal of addiction medicine. 2015 Nov 1; 9(6):470-7.
  288. Hayes CJ, Hudson TJ, Phillips MM, Bursac Z, Williams JS, Austin MA, Edlund MJ, Martin BC. The influence of propoxyphene withdrawal on opioid use in veterans. Pharmacoepidemiology and drug safety. 2015 Nov 1; 24(11):1180-8.
  289. Lin LA, Bohnert AS, Ilgen MA, Pfeiffer PN, Ganoczy D, Blow FC. Outpatient Provider Contact Prior to Unintentional Opioid Overdose Among VHA Service Users. Psychiatric services (Washington, D.C.). 2015 Nov 1; 66(11):1149-54.
  290. Maughan BC, Bachhuber MA, Mitra N, Starrels JL. Prescription monitoring programs and emergency department visits involving opioids, 2004-2011. Drug and Alcohol Dependence. 2015 Nov 1; 156:282-8.
  291. Pacula RL, Stein B, Gordon AJ, Dick A, Burns RM, Leslie DL, Sorbero MS. The Impact of State Policies on the Use of Buprenorphine Among Medicaid Enrollees Identified with Opioid Use Disorders. Paper presented at: Addiction Health Services Research Conference; 2015 Oct 16; Marina del Rey, CA.
  292. Stein B, Paula RL, Sorbero M, Gordon AJ, Leslie DL, Burns RM, Shih RA, Dick AW. Disparities in Opioid Agonist Therapy by Race/Ethnicity and HIV Status Among Medicaid-Enrollees with Opioid Use Disorders. Paper presented at: Addiction Health Services Research Conference; 2015 Oct 16; Marina del Rey, CA.
  293. Finlay AK, Bowe T, Sox-Harris AH. Changes in receipt of pharmacotherapy for opioid use disorder among veterans from fiscal years 2012-2013. Paper presented at: Addiction Health Services Research Conference; 2015 Oct 15; Marina del Rey, CA.
  294. Stein BD, Mendelsohn J, Gordon A, Pacula RL, Burns RM, Sorbero M, Dick A. Physician Community Network Structure and Clinically Questionable Prescribing Practices for Medicaid-Enrollees With Opioid Use Disorder. Paper presented at: Addiction Health Services Research Conference; 2015 Oct 15; Marina Del Rey, CA.
  295. Evans E, Kelleghan A, Li L, Min J, Huang D, Urada D, Hser YI, Nosyk B. Gender differences in mortality among treated opioid dependent patients. Drug and Alcohol Dependence. 2015 Oct 1; 155:228-35.
  296. Hawkins EJ, Malte CA, Grossbard JR, Saxon AJ. Prevalence and Trends of Concurrent Opioid Analgesic and Benzodiazepine Use Among Veterans Affairs Patients with Post-traumatic Stress Disorder, 2003-2011. Pain medicine (Malden, Mass.). 2015 Oct 1; 16(10):1943-54.
  297. Nosyk B, Min JE, Evans E, Li L, Liu L, Lima VD, Wood E, Montaner JS. The Effects of Opioid Substitution Treatment and Highly Active Antiretroviral Therapy on the Cause-Specific Risk of Mortality Among HIV-Positive People Who Inject Drugs. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2015 Oct 1; 61(7):1157-65.
  298. Schulte M, Hser Y, Saxon A, Evans E, Li L, Huang D, Hillhouse M, Thomas C, Ling W. Risk Factors Associated with HCV Among Opioid-Dependent Patients in a Multisite Study. Journal of community health. 2015 Oct 1; 40(5):940-7.
  299. Trafton JA, Henderson P, Paik M, Tavakoli S, Bowe T, Oliver J, Midboe AM, Lewis ET. VA Opioid Therapy Clinical Practice Guideline Adherence Report: Customizable intranet-based report of facility-level adherence to guideline recommended care practice to improve the safety and efficacy of opioid prescribing for pain. 2015 Oct 1. Available from: http://vssc.med.va.gov/VSSCAgreements/Default.aspx?locn=http%3A//vssc.med.va.gov/uat.asp..
  300. Hawkins EJ, Malte CA, Saxon AJ, Sayre G. Evaluating a Medication Alert to Reduce Concurrent Opioid and Benzodiazepine Use at a Single VA Health Care System. Paper presented at: Society for Implementation Research Collaboration Biennial Conference on Advancing Efficient Methodologies Through Community Partnerships and Team Science; 2015 Sep 10; Seattle, WA.
  301. Gordon AJ, Oliva EM, Wells DL, Harding JD. Opioid overdose education and naloxone distribution to prevent opioid overdose mortality [Buprenorphine Initiative in the VA Monthly Webinar Series]. [Cyberseminar]. 2015 Sep 8.
  302. Buscaglia AC, Lewis ET, Trafton JA, VA Opioid Metric Development Team. Baseline Variation in Use of VA/DOD Clinical Practice Guideline Recommended Opioid Prescribing Practices Across VA Health Care Systems. The Clinical Journal of Pain. 2015 Sep 1; 31(9):803-812.
  303. Stein BD, Pacula RL, Gordon AJ, Burns RM, Leslie DL, Sorbero MJ, Bauhoff S, Mandell TW, Dick AW. Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties. The Milbank Quarterly. 2015 Sep 1; 93(3):561-83.
  304. Ashrafioun L, Bohnert AS, Jannausch M, Ilgen MA. Evaluation of the current opioid misuse measure among substance use disorder treatment patients. Journal of substance abuse treatment. 2015 Aug 1; 55:15-20.
  305. Bair MJ, Bohnert AS. Overdoses in Patients on Opioids: Risks Associated with Mental Health Conditions and Their Treatment. [Editorial]. Journal of general internal medicine. 2015 Aug 1; 30(8):1051-3.
  306. Broyles LM. Getting evidence into real-life practice and systems of care: what SBIRT, opioid agonist treatment, and integrated care look like in the VA. Presented at: Institute for Research, Education, and Training in Addictions Annual Meeting; 2015 Jul 10; Pittsburgh, PA.
  307. Hawkins EJ, Malte CA, Grossbard JR, Saxon AJ. Prevalence and Trends of Concurrent Opioid Analgesic and Benzodiazepine Use Among Veterans Affairs Patients with PTSD 2003-2011. Poster session presented at: VA HSR&D / QUERI National Meeting; 2015 Jul 10; Philadelphia, PA.
  308. Bohnert AS, Levine DA, Ganoczy D, Blow FC. Factors associated with opioid overdose death among VHA patients age 50 and older prescribed opioids. Poster session presented at: VA HSR&D / QUERI National Meeting; 2015 Jul 9; Philadelphia, PA.
  309. Lovejoy TI, Meath THA, Morasco BJ, Demidenko MI, Dobscha SK. Changes in pain intensity and pain treatment utilization in Veterans following discontinuation of long-term opioid therapy. Poster session presented at: VA HSR&D / QUERI National Meeting; 2015 Jul 9; Philadelphia, PA.
  310. Suda KJ, Bailey LA, Smith BM, Gellad WF, Huo Z, Cunningham F, Burk M, Stroupe KT. Opioid use in Veterans eligible for VA and Medicare Part D and predictors for overlap within and among VA and Medicare Part D-reimbursed pharmacies. Poster session presented at: VA HSR&D / QUERI National Meeting; 2015 Jul 9; Philadelphia, PA.
  311. Finlay AK, Harris A, Blue-Howells J, Rosenthal J, McGuire J, Binswanger I. Receipt of pharmacotherapy for opioid use disorder: Comparing Justice-involved Veterans with Other Veterans. Poster session presented at: VA HSR&D / QUERI National Meeting; 2015 Jul 8; Philadelphia, PA.
  312. Mudumbai S, Unger-Hu K, Oliva EM, Lewis ET, Trafton JA, Mariano ER, Stafford RS, Wagner TH, Clark D. Time to Cessation of Postoperative Opioids: A National-level, Cross-sectional Analysis of the Veterans Affairs Healthcare System. Paper presented at: VA HSR&D / QUERI National Meeting; 2015 Jul 8; Philadelphia, PA.
  313. Oliva EM, McCaa MD, Lewis ET, Cochran MF, Konicki PE, Wilder CM. Formative Evaluation of Life-Saving Opioid Overdose Education and Naloxone Distribution (OEND) in VISNs 10 and 21. Poster session presented at: VA HSR&D / QUERI National Meeting; 2015 Jul 8; Philadelphia, PA.
  314. Im JJ, Shachter RD, Oliva EM, Henderson PT, Paik MC, Trafton JA, PROGRES Team. Association of Care Practices with Suicide Attempts in US Veterans Prescribed Opioid Medications for Chronic Pain Management. Journal of general internal medicine. 2015 Jul 1; 30(7):979-91.
  315. Oliva EM. Saving Veterans Lives through Implementation of Opioid Overdose Education and Naloxone Distribution (OEND). Presented at a Public Hearing on Exploring Naloxone Uptake and Use. Federal Drug Administration Center for Drug Evaluation and Research; 2015 Jul 1; Silver Spring, MD. 2015 Jul 1.
  316. Barry DT, Sofuoglu M, Kerns RD, Wiechers IR, Rosenheck RA. Prevalence and correlates of co-prescribing psychotropic medications with long-term opioid use nationally in the Veterans Health Administration. Psychiatry Research. 2015 Jun 30; 227(2-3):324-32.
  317. Bohnert AS, Blow FC, Cunningham R, Thomas L, Greenwald MK, Chermack S, Bonar EE, Walton M. A randomized clinical trial of a behavioral intervention to reduce opioid overdose risk behavior. Paper presented at: College on Problems of Drug Dependence Annual Meeting; 2015 Jun 15; Phoenix, AZ.
  318. Marcus SC, Olfson M, Amos T, Durkin M. Patient characteristics and acute care service use of Medicare beneficiaries meeting opioid overutilization criteria. Poster session presented at: AcademyHealth Annual Research Meeting; 2015 Jun 15; Minneapolis, MN.
  319. Maughan B, Bachhuber MA, Mitra N, Starrels J. Prescription monitoring program implementation was not associated with changes in emergency department visits involving opioid analgesics. Poster session presented at: AcademyHealth Annual Research Meeting; 2015 Jun 15; Minneapolis, MN.
  320. Finlay AK, Harris A, Blue-Howells J, Rosenthal J, McGuire J, Binswanger I. Receipt of pharmacotherapy for opioid use disorder: Comparing Veterans in Veterans Justice Programs with other Veterans. Poster session presented at: AcademyHealth Annual Research Meeting; 2015 Jun 14; Minneapolis, MN.
  321. Banerjee G, Edelman EJ, Barry DT, Becker W, Cerda M, Crystal S, Gaither JR, Gordon A, Kerns R, Martins SS, Fiellin DA, Marshall BD. Incident Non-Medical Use of Prescription Opioids is Associated with Heroin Initiation Among US Veterans: A Prospective Cohort Study. Poster session presented at: College on Problems of Drug Dependence Annual Meeting; 2015 Jun 13; Phoenix, AZ.
  322. Edelman E, Tate J, Gordon K, Becker W, Bryant K, Crothers K, Gaither J, Gibert CL, Gordon A, Marshall BD, Rodriguez-Barradas M, Samet JH, Skanderson M, Justice A, Fiellin D. Do prescribed opioids impact CD4 count restoration among HIV+ patients initiating antiretroviral therapy? Poster session presented at: College on Problems of Drug Dependence Annual Meeting; 2015 Jun 13; Phoenix, AZ.
  323. Park TW, Saitz R, Ganoczy D, Ilgen MA, Bohnert AS. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ (Clinical research ed.). 2015 Jun 10; 350:h2698.
  324. Dick AW, Pacula RL, Gordon AJ, Sorbero M, Burns RM, Leslie D, Stein BD. Growth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002-11. Health affairs (Project Hope). 2015 Jun 1; 34(6):1028-34.
  325. Weisberg DF, Gordon KS, Barry DT, Becker WC, Crystal S, Edelman EJ, Gaither J, Gordon AJ, Goulet J, Kerns RD, Moore BA, Tate J, Justice AC, Fiellin DA. Long-term Prescription of Opioids and/or Benzodiazepines and Mortality Among HIV-Infected and Uninfected Patients. Journal of acquired immune deficiency syndromes (1999). 2015 Jun 1; 69(2):223-33.
  326. Comer S, Cunningham C, Fishman MJ, Gordon AJ, Kampman K, Langleben D, Nordstrom B, Oslin D, Woody G, Wright T, Wyatt S. American Society of Addiction Medicine National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use. 2015 May 27.
  327. Dobscha SK. Changes in Pain Intensity Over Time in a National Cohort of Older Veterans: Exploring Associations of Pain Scores with Prescription Opioids. [Cyberseminar]. 2015 May 5.
  328. Mosher HJ, Krebs EE, Carrel M, Kaboli PJ, Weg MW, Lund BC. Trends in prevalent and incident opioid receipt: an observational study in Veterans Health Administration 2004-2012. Journal of general internal medicine. 2015 May 1; 30(5):597-604.
  329. Rogal SS, Bielefeldt K, Wasan AD, Lotrich FE, Zickmund S, Szigethy E, DiMartini AF. Inflammation, psychiatric symptoms, and opioid use are associated with pain and disability in patients with cirrhosis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2015 May 1; 13(5):1009-16.
  330. Westanmo A, Marshall P, Jones E, Burns K, Krebs EE. Opioid Dose Reduction in a VA Health Care System--Implementation of a Primary Care Population-Level Initiative. Pain medicine (Malden, Mass.). 2015 May 1; 16(5):1019-26.
  331. Becker W, Tate JP, Edelman EJ, Gaither J, Akgun K, Barry D, Crystal S, Gordon A, Merlin JS, Kerns RD, Justice AC, Fiellin DA. The Relationship Among Opioid Use, HIV, and Accidental Death: Is It In the Eye of the Beholder? Poster session presented at: Society of General Internal Medicine Annual Meeting; 2015 Apr 24; Toronto, Canada.
  332. Krebs EE, Kroenke K, Wu J, Bair MJ, Yu Z. Baseline opioid use as a predictor of telecare collaborative pain management outcomes. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2015 Apr 23; Toronto, Canada.
  333. Bohnert AS. Preventing prescription opioid overdoses: Changing prescribing practices and patients’ risky opioid use. Paper presented at: VA VISN 11 Opioid Safety Initiative and Pain Management Seminar; 2015 Apr 22; Fort Wayne, IN.
  334. Edelman EJ, Tate JP, Gordon KS, Becker WC, Bryant K, Crothers K, Gaither J, Gibert CL, Gordon A, Marshall BD, Rodriguez-Barradas M, Samet JH, Skanderson M, Justice AC, Fiellin DA. Do prescribed opioids impact CD4 count restoration among HIV+ patients initiating antiretroviral therapy. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2015 Apr 22; Toronto, Canada.
  335. Bohnert AS. Preventing prescription opioid overdoses: Changing prescribing practices and patients’ risky opioid use. Paper presented at: VA Palo Alto Center for Innovation to Implementation Seminar Series; 2015 Apr 20; Palo Alto, CA.
  336. Ilgen MA. Opioid dose and risk of suicide mortality. Paper presented at: American Association of Suicidology Annual Conference; 2015 Apr 17; Atlanta, GA.
  337. Bohnert AS. Preventing prescription opioid overdoses: Changing prescribing practices and patients’ risky opioid use. Paper presented at: Kaiser Permanente Division of Research Annual Meeting; 2015 Apr 16; San Francisco, CA.
  338. Farmer CM, Lindsay D, Williams J, Ayers A, Schuster J, Cilia A, Flaherty MT, Mandell T, Gordon AJ, Stein BD. Practice guidance for buprenorphine for the treatment of opioid use disorders: results of an expert panel process. Substance Abuse. 2015 Apr 6; 1-8.
  339. Bachhuber MA, Saloner B, Barry CL. What ecologic analyses cannot tell us about medical marijuana legalization and opioid pain medication mortality--reply. JAMA internal medicine. 2015 Apr 1; 175(4):656-7.
  340. Finney JW, Humphreys K, Harris AH. What ecologic analyses cannot tell us about medical marijuana legalization and opioid pain medication mortality. [Letter to the Editor]. JAMA internal medicine. 2015 Apr 1; 175(4):655-6.
  341. Hughes HK, Korthuis PT, Saha S, Eggly S, Sharp V, Cohn J, Moore R, Beach MC. A mixed methods study of patient-provider communication about opioid analgesics. Patient education and counseling. 2015 Apr 1; 98(4):453-61.
  342. Lovejoy TI, Dobscha SK, Turk DC, Weimer MB, Morasco BJ. Predictors of prescription opioid therapy in patients with chronic pain and a history of substance use disorder. [Abstract]. The journal of pain : official journal of the American Pain Society. 2015 Apr 1; 16(1):S84.
  343. Bohnert AS. Prescription drug abuse, overdose, and responsible opioid prescribing. Paper presented at: Oakland County Health Division, Prescription Drug Abuse and Overdose Prevention Collaborative Meeting; 2015 Mar 20; Pontiac, MI.
  344. Finlay AK, Binswanger I, Frayne SM, Harris A. Receipt of pharmacotherapy for opioid use disorder: Comparing justice-involved Veterans with other Veterans. Presented at: Academic and Health Policy Conference on Correctional Health; 2015 Mar 19; Boston, MA.
  345. Lee JD, Friedmann PD, Boney TY, Hoskinson RA, McDonald R, Gordon M, Fishman M, Chen DT, Bonnie RJ, Kinlock TW, Nunes EV, Cornish JW, O'Brien CP. Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: rationale and design of a randomized controlled effectiveness trial. Contemporary clinical trials. 2015 Mar 1; 41:110-7.
  346. Cochran G, Woo B, Lo-Ciganic WH, Gordon AJ, Donohue JM, Gellad WF. Defining nonmedical use of prescription opioids within health care claims: a systematic review. Substance Abuse. 2015 Feb 11; 36(2):192-202.
  347. Krebs EE. Opioid therapy for chronic pain. Pain, Opioids, and Addiction education series. 2015 Feb 10.
  348. Larney S, Bohnert AS, Ganoczy D, Ilgen MA, Hickman M, Blow FC, Degenhardt L. Mortality among older adults with opioid use disorders in the Veteran's Health Administration, 2000-2011. Drug and Alcohol Dependence. 2015 Feb 1; 147:32-7.
  349. Oliva EM. Implementing Opioid Overdose Education and Naloxone Distribution (OEND) to Prevent Opioid Overdose Mortality. Presented at: VA / Department of Defense Suicide Prevention Annual Conference; 2015 Jan 28; Dallas, TX.
  350. Becker WC, Ganoczy D, Fiellin DA, Bohnert AS. Buprenorphine/Naloxone dose and pain intensity among individuals initiating treatment for opioid use disorder. Journal of substance abuse treatment. 2015 Jan 1; 48(1):128-31.
  351. Dick A, Pacula R, Gordon AJ, Sorbero M, Burns RM, Farmer C, Leslie D, Stein BD. Increasing access to opioid agonist treatment in US treatment shortage areas. [Abstract]. Drug and Alcohol Dependence. 2015 Jan 1; 146:E266.
  352. Gordon AJ, Jenkins JA. The Time Is Now: The Role of Pharmacotherapies in Expanding Treatment for Opioid Use Disorder. [Editorial]. Substance Abuse. 2015 Jan 1; 36(2):127-8.
  353. Gordon AJ, Lo Ciganic W, Cochran G, Gellad WF, Donohue JM. Characteristics of buprenorphine opioid agonist treatment in a longitudinal US Medicaid population. [Abstract]. Drug and Alcohol Dependence. 2015 Jan 1; 146:E126.
  354. Morasco BJ, Krebs EE, Cavanagh R, Hyde S, Crain A, Dobscha SK. Treatment changes following aberrant urine drug test results for patients prescribed chronic opioid therapy. Journal of opioid management. 2015 Jan 1; 11(1):45-51.
  355. Pacula RL, Gordon AJ, Dick AW, Burns RM, Farmer C, Leslie D, Sorbero M, Stein BD. Expansion of buprenorphine opioid agonist therapy in the United States: facility-level factors. [Abstract]. Drug and Alcohol Dependence. 2015 Jan 1; 146:E179.
  356. Peng X, Robinson RL, Mease P, Kroenke K, Williams DA, Chen Y, Faries D, Wohlreich M, McCarberg B, Hann D. Long-term evaluation of opioid treatment in fibromyalgia. The Clinical Journal of Pain. 2015 Jan 1; 31(1):7-13.
  357. Stein BD, Gordon AJ, Dick A, Burns RM, Pacula R, Farmer C, Leslie D. Physician supply for the treatment of opioid use disorders: the influence of state policies. [Abstract]. Drug and Alcohol Dependence. 2015 Jan 1; 146:e107-e108.
  358. Tierney M, Finnell DS, Naegle MA, LaBelle C, Gordon AJ. Advanced Practice Nurses: Increasing Access to Opioid Treatment by Expanding the Pool of Qualified Buprenorphine Prescribers. Substance Abuse. 2015 Jan 1; 36(4):389-92.
  359. Dorflinger L, Moore B, Goulet J, Becker W, Heapy AA, Sellinger JJ, Kerns RD. A partnered approach to opioid management, guideline concordant care and the stepped care model of pain management. Journal of general internal medicine. 2014 Dec 1; 29 Suppl 4:870-6.
  360. Vanderlip ER, Sullivan MD, Edlund MJ, Martin BC, Fortney J, Austen M, Williams JS, Hudson T. National study of discontinuation of long-term opioid therapy among veterans. Pain. 2014 Dec 1; 155(12):2673-9.
  361. Mudumbai S, Unger-Hu K, Oliva E, Lewis E, Trafton J, Mariano ER, Stafford RS, Wagner T, Clark D. Adverse Outcomes associated with Types of Postoperative Opioid Use: A Population-level Study of the Veterans Affairs Healthcare System. Paper presented at: American Society of Regional Anesthesia and Pain Medicine Annual Pain Medicine Meeting; 2014 Nov 13; San Francisco, CA.
  362. Cochran G, Woo B, Donohue J, Gordon A, Lo-Ciganic W, Gellad W. Defining non-medical use of prescription opioids within health insurance claims data: a systematic review. Paper presented at: Association for Medical Education and Research in Substance Abuse Annual Meeting; 2014 Nov 7; San Francisco, CA.
  363. Lewis ET. What we know about opioid adherence might surprise you: findings from a qualitative study of opioid use behaviors. HSR&D Spotlight on Pain Management. [Cyberseminar]. 2014 Nov 4.
  364. Bachhuber MA, Saloner B, Cunningham CO, Feingold J, Barry CL. Could Delaware's medical marijuana law reduce harms from opioid analgesics? Delaware medical journal. 2014 Nov 1; 86(11):341-3.
  365. Edlund MJ, Austen MA, Sullivan MD, Martin BC, Williams JS, Fortney JC, Hudson TJ. Patterns of opioid use for chronic noncancer pain in the Veterans Health Administration from 2009 to 2011. Pain. 2014 Nov 1; 155(11):2337-43.
  366. Gaither JR, Goulet JL, Becker WC, Crystal S, Edelman EJ, Gordon K, Kerns RD, Rimland D, Skanderson M, Weisberg DF, Justice AC, Fiellin DA. Guideline-concordant management of opioid therapy among human immunodeficiency virus (HIV)-infected and uninfected veterans. The journal of pain : official journal of the American Pain Society. 2014 Nov 1; 15(11):1130-40.
  367. Krebs EE, Bergman AA, Coffing JM, Campbell SR, Frankel RM, Matthias MS. Barriers to guideline-concordant opioid management in primary care--a qualitative study. The journal of pain : official journal of the American Pain Society. 2014 Nov 1; 15(11):1148-55.
  368. Morasco BJ, O'Hearn D, Turk DC, Dobscha SK. Associations between prescription opioid use and sleep impairment among veterans with chronic pain. Pain medicine (Malden, Mass.). 2014 Nov 1; 15(11):1902-10.
  369. Good CB. VA response to FDA abuse-deterrent opioid medications initiative [invited presentation]. Presented at: Development and Regulation of Abuse-Deterrent Opioid Medications FDA Public Meeting; 2014 Oct 30; Silver Spring, MD.
  370. Bauhoff S, Stein BD, Pacula RL, Dick AW, Gordon AJ, Burns RM, Leslie DL. Do Substance Abuse Policies Influence Opioid Agonist therapies in Substance Abuse Treatment Facilities. Poster session presented at: Addiction Health Services Research Conference; 2014 Oct 16; Boston, MA.
  371. Stein BD, Dick SW, Sorbero M, Burns RM, Pacula RL, Gordon AJ, Leslie DL. Patterns of buprenorphine use among Medicaid-enrolled individuals with opioid use disorders. Poster session presented at: Addiction Health Services Research Conference; 2014 Oct 16; Boston, MA.
  372. Mudumbai S, Unger-Hu K, Oliva E, Lewis E, Trafton J, Mariano ER, Stafford RS, Wagner T, Clark D. Time to Cessation of Postoperative Opioids: A National-level, Cross-sectional Analysis of the Veterans Affairs Healthcare System. Paper presented at: American Society of Anesthesiologists Annual Meeting; 2014 Oct 11; New Orleans, LA.
  373. Cavanagh R, Gritzner S, Dobscha SK, Morasco BJ. Aberrant medication-related behaviors do not differ based on opioid dose: Results from a comprehensive medical record review. Presented at: International Association for the Study of Pain Annual Meeting; 2014 Oct 7; Buenos Aires, Brazil.
  374. Bachhuber MA, Saloner B, Cunningham CO, Barry CL. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. JAMA internal medicine. 2014 Oct 1; 174(10):1668-73.
  375. Park TW, Friedmann PD. Medications for addiction treatment: an opportunity for prescribing clinicians to facilitate remission from alcohol and opioid use disorders. Rhode Island medical journal. 2014 Oct 1; 97(10):20-4.
  376. Krebs EE. Opioid Risk Mitigation and Adherence Monitoring in Practice. Presented at: National Institutes of Health Office of Disease Prevention Quarterly Workshop; 2014 Sep 30; Bethesda, MD.
  377. Trafton JA. Implementing Guideline Recommendations for Improving the Safety and Effectiveness of Opioid Therapy: Strategies and Lessons Learned From the VHA. Presented at: Conquering Pain Locally, Regionally and Nationally Conference; 2014 Sep 20; Stanford, CA.
  378. Humphreys KN. Damned If We Do... Can We Relieve Pain and Stop Opioid Abuse At the Same Time? Presented at: Conquering Pain Locally, Regionally and Nationally Conference; 2014 Sep 19; Stanford, CA.
  379. Cobaugh DJ, Gainor C, Gaston CL, Kwong TC, Magnani B, McPherson ML, Painter JT, Krenzelok EP. The opioid abuse and misuse epidemic: implications for pharmacists in hospitals and health systems. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2014 Sep 15; 71(18):1539-54.
  380. Oliva EM. Opioid Interventions: Naloxone and Other Option. Teleconference. Presented at: VA VISN 23 Substance Use Disorders Programs Conference; 2014 Sep 11; Menlo Park, CA.
  381. Oliva EM. Spotlight on Pain Management - Opioid Overdose Education and Naloxone Distribution (OEND): Preventing and Responding to an Opioid Overdose. [Cyberseminar]. 2014 Sep 2.
  382. Grossbard JR, Malte CA, Saxon AJ, Hawkins EJ. Clinical monitoring and high-risk conditions among patients with SUD newly prescribed opioids and benzodiazepines. Drug and Alcohol Dependence. 2014 Sep 1; 142:24-32.
  383. Back SE, Gros DF, McCauley JL, Flanagan JC, Cox E, Barth KS, Brady KT. Laboratory-induced cue reactivity among individuals with prescription opioid dependence. Addictive Behaviors. 2014 Aug 1; 39(8):1217-23.
  384. Lewis ET, Cucciare MA, Trafton JA. What do patients do with unused opioid medications? The Clinical Journal of Pain. 2014 Aug 1; 30(8):654-62.
  385. Trafton JA, Oliva EM. Legislative strategies other than legalizing illicit opioids may help to reduce overdose fatalities. Addiction (Abingdon, England). 2014 Aug 1; 109(8):1243-4.
  386. Oliva EM, Midboe AM, Lewis ET, Henderson PT, Dalton AL, Im JJ, Seal K, Paik MC, Trafton JA. Sex differences in chronic pain management practices for patients receiving opioids from the Veterans Health Administration. Pain medicine (Malden, Mass.). 2015 Jan 1; 16(1):112-8.
  387. Bohnert AS, Ilgen MA, Trafton JA, Kerns RD, Eisenberg A, Ganoczy D, Blow FC. Trends and regional variation in opioid overdose mortality among Veterans Health Administration patients, fiscal year 2001 to 2009. The Clinical Journal of Pain. 2014 Jul 1; 30(7):605-12.
  388. Matthias MS, Krebs EE, Bergman AA, Coffing JM, Bair MJ. Communicating about opioids for chronic pain: a qualitative study of patient attributions and the influence of the patient-physician relationship. European journal of pain (London, England). 2014 Jul 1; 18(6):835-43.
  389. Goulet JL, Becker WC, Kerns RD, Justice AC, Fiellin D. Guideline-concordant management of opioid therapy among patients with and without unhealthy alcohol use. Poster session presented at: Research Society on Alcoholism Annual Scientific Meeting; 2014 Jun 21; Bellevue, WA.
  390. Becker WC, Ganoczy D, Fiellin DA, Bohnert AS. Buprenorphine/naloxone dose and pain intensity among individuals initiating treatment for opioid use disorder. Poster session presented at: College on Problems of Drug Dependence Annual Meeting; 2014 Jun 19; San Juan, Puerto Rico.
  391. Dick A, Pacula R, Gordon AJ, Sorbero M, Burns RM, Farmer C, Leslie D, Stein BD. Increasing access to opioid agonist treatment in US treatment shortage areas. Poster session presented at: College on Problems of Drug Dependence Annual Meeting; 2014 Jun 16; San Juan, Puerto Rico.
  392. Edelman EJ, Gordon KS, Becker W, Gaiter JR, Gordon AJ, Samet J, Justice A, Fiellin D. The impact of prescription opioids on CD4 count in HIV: a longitudinal analysis. Poster session presented at: College on Problems of Drug Dependence Annual Meeting; 2014 Jun 16; San Juan, Puerto Rico.
  393. Gordon AJ, Lo Ciganic W, Cochran G, Gellad WF, Donohue JM. Characteristics of buprenorphine opioid agonist treatment in a longitudinal US Medicaid Population. Poster session presented at: College on Problems of Drug Dependence Annual Meeting; 2014 Jun 16; San Juan, Puerto Rico.
  394. Pacula RL, Gordon AJ, Dick AW, Burns RM, Farmer C, Leslie D, Sorbero M, Stein BD. Expansion of buprenorphine opioid agonist therapy in the United States: facility-level factors. Poster session presented at: College on Problems of Drug Dependence Annual Meeting; 2014 Jun 16; San Juan, Puerto Rico.
  395. Stein BD, Gordon AJ, Dick A, Burns RM, Pacula R, Farmer C, Leslie D. Physician supply for the treatment of opioid use disorders: the influence of state policies. Poster session presented at: College on Problems of Drug Dependence Annual Meeting; 2014 Jun 16; San Juan, Puerto Rico.
  396. Fiellin D, Justice AC. Using the VACS index to track health outcomes associated with abstinence among HIV-infected patients receiving opioid agonist treatment. Poster session presented at: College on Problems of Drug Dependence Annual Meeting; 2014 Jun 14; San Juan, Puerto Rico.
  397. Justice AC, Goulet JL, Becker WC, Fiellin D. Receipt of opioid therapy guideline-concordant care among HIV-infected and uninfected Veterans. Poster session presented at: College on Problems of Drug Dependence Annual Meeting; 2014 Jun 14; San Juan, Puerto Rico.
  398. Krein SL, Bohnert AS, Kim M, Harris ME, Richardson CR. Opioid Use and Walking Among Patients with Chronic Low Back Pain. Poster session presented at: AcademyHealth Annual Research Meeting; 2014 Jun 10; San Diego, CA.
  399. Hudson TJ, Williams S, Austen MA, Martin B, Sullivan M, Fortney JC, Edlund MJ. Opioid use among OEF/OIF Veterans with Traumatic Brain Injury. Poster session presented at: AcademyHealth Annual Research Meeting; 2014 Jun 9; San Diego, CA.
  400. Justice AC, Becker WC, Fiellin D, Kerns RD. Racial differences in receipt of opioid therapy guideline-concordant care. Poster session presented at: International Conference on Opioids; 2014 Jun 8; Boston, MA.
  401. Broyles LM. Getting evidence into real-life practice and systems of care: what SBIRT, opioid agonist treatment, and integrated care look like in the VA (Presentation for Advanced Medical Student Fellowship in Alcohol and Other Drug Dependency; Institute for Research, Education and Training in Addictions, Pittsburgh, PA). 2014 Jun 4.
  402. Burgess DJ, Phelan S, Workman M, Hagel E, Nelson DB, Fu SS, Widome R, van Ryn M. The effect of cognitive load and patient race on physicians' decisions to prescribe opioids for chronic low back pain: a randomized trial. Pain medicine (Malden, Mass.). 2014 Jun 1; 15(6):965-74.
  403. Clarke TK, Crist RC, Ang A, Ambrose-Lanci LM, Lohoff FW, Saxon AJ, Ling W, Hillhouse MP, Bruce RD, Woody G, Berrettini WH. Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females. The Pharmacogenomics Journal. 2014 Jun 1; 14(3):303-8.
  404. Oliva EM, Konicki PE. Opioid Risk Mitigation and the Role of Naloxone Rescue. Oral presentation (Adobe Connect webinar) to VA SCAN-ECHO (Specialty Care Access Network-Extension for Community Healthcare Outcomes). [Cyberseminar]. 2014 May 27.
  405. Okunseri C, Okunseri E, Xiang Q, Thorpe JM, Szabo A. Prescription of opioid and nonopioid analgesics for dental care in emergency departments: Findings from the National Hospital Ambulatory Medical Care Survey. Journal of public health dentistry. 2014 May 26; 74(4):283-92.
  406. Oliva EM, Burgard J, Drexler K. Overdose Education and Naloxone Distribution (OEND) to Prevent Opioid Overdose. Oral presentation (telephone conference) to the VISN 23 Substance Use Disorder (SUD) Leads. 2014 May 2.
  407. Bachhuber MA, Southern WN, Cunningham CO. Profiting and providing less care: comprehensive services at for-profit, nonprofit, and public opioid treatment programs in the United States. Medical care. 2014 May 1; 52(5):428-34.
  408. Kerns RD, Goulet JL, Dorflinger L, Moore BA. Opioid prescribing and the Stepped Care Model of Pain Management in the Veteran's Health Administration. Poster session presented at: American Pain Society Annual Meeting; 2014 May 1; Tampa, FL.
  409. Becker WC. Recent trends and regional variation in opioid analgesic exposure in the Veterans Health Administration. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2014 Apr 26; San Diego, CA.
  410. Justice AC, Becker WC, Goulet JL, Kerns RD, Moore BA, Fiellin D. Association of Long-Term Opioid and/or Benzodiazepine Receipt and Medication Count with Mortality among HIV-Infected and Uninfected Patients. Paper presented at: Society of General Internal Medicine Annual Meeting; 2014 Apr 23; San Diego, CA.
  411. Krebs EE, Paudel M, Taylor BC, Bauer D, Fink HA, Lane N, Ensrud KE. Association of opioid use with falls and fractures among older men. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2014 Apr 23; San Diego, CA.
  412. Hudson TJ, Martin BC, Sullivan M, Fortney JC, Austen MA, Williams S, Edlund MJ. Population-level analysis of opioid use among Veterans. Poster session presented at: Association for Clinical Research Training / Society for Clinical and Translational Science / American Federation for Medical Research Translational Science Meeting; 2014 Apr 11; Washington, DC.
  413. Burgess DJ, Nelson DB, Gravely AA, Bair MJ, Kerns RD, Higgins DM, van Ryn M, Farmer M, Partin MR. Racial differences in prescription of opioid analgesics for chronic noncancer pain in a national sample of veterans. The journal of pain : official journal of the American Pain Society. 2014 Apr 1; 15(4):447-55.
  414. Matthias MS. Communicating about Opioids for Chronic Pain: What Really Happens in Clinic Visits? [Cyberseminar]. 2014 Apr 1.
  415. Donohue JM, Lo-Ciganic WH, Cochran G, Gordon AJ, Zemaitis MA, Gellad WF. Opioid use, opioid use disorder and buprenorphine use in Pennsylvania Medicaid. Philadelphia, PA: Commonwealth of Pennsylvania Department of Public Welfare, Office of Medical Assistance Programs; 2014 Mar 31. 42 p.
  416. Trafton JA, Oliva EM. Overdose Education and Naloxone Distribution (OEND) to Prevent Opioid Overdose. Oral presentation (telephone conference) to the VA Chiefs of Staff. 2014 Mar 27.
  417. Justice AC, Goulet JL, Kerns RD, Fiellin D. Receipt of opioid therapy guideline-concordant care among HIV-infected and uninfected Veterans. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2014 Mar 7; Boston, MA.
  418. Sullivan M, Vanderlip E, Hudson TJ, Edlund MJ, Martin BC, Fortney JC, Landes RD, Austen MA, Williams S. National study of discontinuation of chronic opioid therapy among Veterans. Paper presented at: American Academy of Pain Medicine Annual Meeting; 2014 Mar 7; Phoenix, AZ.
  419. Trafton JA. Spotlight on Pain Management: Quality Improvement and Implementation Support to Improve Use of Guideline Recommended Practices for Chronic Opioid Therapy. [Cyberseminar]. 2014 Mar 4.
  420. Scherrer JF, Svrakic DM, Freedland KE, Chrusciel T, Balasubramanian S, Bucholz KK, Lawler EV, Lustman PJ. Prescription opioid analgesics increase the risk of depression. Journal of general internal medicine. 2014 Mar 1; 29(3):491-9.
  421. Mosher HJ, Jiang L, Vaughan Sarrazin MS, Cram P, Kaboli PJ, Vander Weg MW. Prevalence and characteristics of hospitalized adults on chronic opioid therapy. Journal of hospital medicine. 2014 Feb 1; 9(2):82-7.
  422. Bonar EE, Ilgen MA, Walton M, Bohnert AS. Associations among pain, non-medical prescription opioid use, and drug overdose history. The American journal on addictions. 2014 Jan 1; 23(1):41-7.
  423. Park TW, Bohnert AS, Austin KL, Saitz R, Pizer SD. Datapoints: regional variation in benzodiazepine prescribing for patients on opioid agonist therapy. Psychiatric services (Washington, D.C.). 2014 Jan 1; 65(1):4.
  424. Porucznik CA, Johnson EM, Rolfs RT, Sauer BC. Specialty of prescribers associated with prescription opioid fatalities in Utah, 2002-2010. Pain medicine (Malden, Mass.). 2014 Jan 1; 15(1):73-8.
  425. Thorson D, Biewen P, Bonte B, Epstein H, Haake B, Hansen C, Hooten M, Hora J, Johnson C, Keeling F, Kokayeff A, Krebs EE, Myers C, Nelson B, Noonan MP, Reznikoff C, Thiel M, Trujillo A, Van Pelt S, Wainio J. Acute Pain Assessment and Opioid Prescribing Protocol. Bloomington, MN: Institute for Clinical Systems Improvement; 2014 Jan 1. 44 p.
  426. Bachhuber MA, Cunningham CO. Changes in testing for human immunodeficiency virus, sexually transmitted infections, and hepatitis C virus in opioid treatment programs. JAMA. 2013 Dec 25; 310(24):2671-2.
  427. Morasco BJ, Cavanagh R, Gritzner S, Dobscha SK. Care management practices for chronic pain in veterans prescribed high doses of opioid medications. Family Practice. 2013 Dec 1; 30(6):671-8.
  428. Saxon AJ, Hser YI, Woody G, Ling W. Medication-assisted treatment for opioid addiction: methadone and buprenorphine. Journal of food and drug analysis. 2013 Dec 1; 21(4):S69-S72.
  429. Gros DF, Back SE, McCauley J, Mercer MA, LaRowe S, Brady KT. Examination of prescription opioid cue-induced subjective, physiological, and neuroendocrine reactivity. Poster session presented at: Association for Behavioral and Cognitive Therapies Annual Convention; 2013 Nov 21; Nashville, TN.
  430. Gros DF, De Leo JA, Back SE. Comparing self-report mood-related symptomatology and addiction severity in a sample of prescription opioid dependent and non-dependent individuals. Poster session presented at: Association for Behavioral and Cognitive Therapies Annual Convention; 2013 Nov 21; Nashville, TN.
  431. Gros DF, De Leo JA, Back SE, Milanak ME, Brady KT. Comparing clinical profiles of prescription opioid dependent individuals with and without comorbid mood and anxiety disorders. Poster session presented at: Association for Behavioral and Cognitive Therapies Annual Convention; 2013 Nov 21; Nashville, TN.
  432. Painter JT, Crofford LJ, Talbert J. Geographic variation of chronic opioid use in fibromyalgia. Poster session presented at: International Society for Pharmacoepidemiology Annual Conference; 2013 Nov 3; Washington, DC.
  433. Bachhuber MA, Cunningham CO. For-profit treatment of opioid addiction. [Letter to the Editor]. Health affairs (Project Hope). 2013 Nov 1; 32(11):2060.
  434. Matthias MS, Krebs EE, Collins LA, Bergman AA, Coffing J, Bair MJ. "I'm not abusing or anything": patient-physician communication about opioid treatment in chronic pain. Patient education and counseling. 2013 Nov 1; 93(2):197-202.
  435. Edlund MJ, Sullivan M, Martin BC, Fortney JC, Landes RD, Austen MA, Williams S, Hudson TJ. Patterns of opioid use among Veterans with chronic non-cancer pain. Paper presented at: Addiction Health Services Research Conference; 2013 Oct 25; Portland, OR.
  436. Hayes C, Phillips M, Martin BC, Bursac Z, Williams S, Hudson TJ. The influence of the propoxyphene withdrawal on opioid use and opioid related adverse events in Veterans. Paper presented at: Addiction Health Services Research Conference; 2013 Oct 25; Portland, OR.
  437. Hudson TJ, Edlund MJ, Martin BC, Sullivan M, Fortney JC, Landes RD, Austen MA, Williams S. National analysis of opioid use among Veterans. Paper presented at: Addiction Health Services Research Conference; 2013 Oct 25; Portland, OR.
  438. Hudson TJ, Pope R, Williams S, Martin BC, Sullivan M, Fortney JC, Landes RD, Edlund MJ. Opioid use among OEF/OIF/OND Veterans with traumatic brain injury. Paper presented at: Addiction Health Services Research Conference; 2013 Oct 25; Portland, OR.
  439. Stein BD, Gordon AJ, Dick AW, Burns RM, Pacula RL, Farmer CM, Leslie DL, Sorbero M. Physician supply for the treatment of opioid addiction: the influence of state policies. Paper presented at: Addiction Health Services Research Conference; 2013 Oct 24; Portland, OR.
  440. Grossbard J, Malte CA, Saxon AJ, Hawkins EJ, Hawkins EJ. Clinical Monitoring and High-Risk Conditions Among Patients With SUD Newly Prescribed Opioids and Benzodiazepines. Presented at: Addiction Health Services Research Conference; 2013 Oct 23; Portland, OR.
  441. Becker WC, Fraenkel L, Kerns RD, Fiellin DA. A research agenda for enhancing appropriate opioid prescribing in primary care. Journal of general internal medicine. 2013 Oct 1; 28(10):1364-7.
  442. Dobscha SK. Prescription opioids and benzodiazepines: moving beyond "just say no". Pain medicine (Malden, Mass.). 2013 Oct 1; 14(10):1447-9.
  443. Ford AC, Brenner DM, Schoenfeld PS. Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and meta-analysis. The American journal of gastroenterology. 2013 Oct 1; 108(10):1566-74; quiz 1575.
  444. Trafton JA, Henderson P, Paik M, Tavakoli S, Bowe T, Oliver J, Midboe AM, Lewis ET. VA Opioid Therapy Clinical Practice Guideline Adherence Report/Too: Customizable intranet-based report of facility-level adherence to guideline recommended care practice to improve the safety and efficacy of opioid prescribing for pain (Updated quarterly). 2013 Oct 1.
  445. Humphreys KN. Responding to opioid and methamphetamine addiction. Paper presented at: Kanawha County Methamphetamine Task Force Meeting; 2013 Sep 19; Charleston, WV.
  446. Crist RC, Clarke TK, Ang A, Ambrose-Lanci LM, Lohoff FW, Saxon AJ, Ling W, Hillhouse MP, Bruce RD, Woody G, Berrettini WH. An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans. Neuropsychopharmacology. 2013 Sep 1; 38(10):2003-10.
  447. Hawkins EJ, Malte CA, Grossbard J, Saxon AJ, Imel ZE, Kivlahan DR. Comparative safety of benzodiazepines and opioids among veterans affairs patients with posttraumatic stress disorder. Journal of addiction medicine. 2013 Sep 1; 7(5):354-62.
  448. Roy-Byrne P, Sullivan MD, Sherbourne CD, Golinelli D, Craske MG, Sullivan G, Stein MB. Effects of pain and prescription opioid use on outcomes in a collaborative care intervention for anxiety. The Clinical Journal of Pain. 2013 Sep 1; 29(9):800-6.
  449. Ford AC, Brenner DM, Schoenfeld PS. Don't forget about constipation with opioid treatment of chronic non-cancer pain. BMJ (Clinical research ed.). 2013 Jul 16; 347:f4492.
  450. Potter JS, Marino EN, Hillhouse MP, Nielsen S, Wiest K, Canamar CP, Martin JA, Ang A, Baker R, Saxon AJ, Ling W. Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START). Journal of studies on alcohol and drugs. 2013 Jul 1; 74(4):605-13.
  451. Rigg KK, Murphy JW. Understanding the etiology of prescription opioid abuse: implications for prevention and treatment. Qualitative Health Research. 2013 Jul 1; 23(7):963-75.
  452. Becker WC, Fraenkel L, Edelman EJ, Holt SR, Glover J, Kerns RD, Fiellin DA. Instruments to assess patient-reported safety, efficacy, or misuse of current opioid therapy for chronic pain: a systematic review. Pain. 2013 Jun 1; 154(6):905-16.
  453. Brenner DM, Ford AC, Schoenfeld P. Efficacy of pharmacological therapies for the treatment of opioid-induced constipation, systematic review and meta-analysis. Poster session presented at: Digestive Disease Week Annual Meeting; 2013 May 18; Orlando, FL.
  454. Deyo RA, Smith DH, Johnson ES, Tillotson CJ, Donovan M, Yang X, Petrik A, Morasco BJ, Dobscha SK. Prescription opioids for back pain and use of medications for erectile dysfunction. Spine (Philadelphia, Pa. : 1986). 2013 May 15; 38(11):909-15.
  455. Hausmann LR, Gao S, Lee ES, Kwoh CK. Racial disparities in the monitoring of patients on chronic opioid therapy [Spotlight on Pain Management Cyberseminar Series]. [Cyberseminar]. 2013 May 7.
  456. Porucznik CA, Johnson EM, Rolfs RT, Sauer BC. Opioid prescribing knowledge and practices: provider survey following promulgation of guidelines-Utah, 2011. Journal of opioid management. 2013 May 1; 9(3):217-24.
  457. Becker WC. Trends in and correlates of opioid receipt among Veterans with and without HIV. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2013 Apr 26; Denver, CO.
  458. Becker WC, Edelman EJ, Gordon K, Kerns RD, Crystal S, Fiellin LE, Gordon AJ, Goulet JL, Justice AC, Fiellin DA. Trends and correlate of opioid analgesic receipt among Veterans with and without HIV: 1999-2010. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2013 Apr 25; Denver, CO.
  459. Mosher HJ, Kaboli PJ. Chronic Opioid Therapy of Hospitalized Patients. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2013 Apr 25; Denver, CO.
  460. Tetrault J, Tate J, Edelman J, Gordon AJ, Vin LR, Crystal S, Fiellin L, Bryant K, Justice AC, Fiellin DA. Use and safety of buprenorphine in HIV-infected and uninfected opioid dependent patients. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2013 Apr 25; Denver, CO.
  461. Bair MJ. Prescribing Opioids for Chronic Pain: A Primary Care 'Toolbox' for Employing Rational Analgesia, Managing Risk, and Enhancing Communication. Paper presented at: American College of Physicians Annual Meeting; 2013 Apr 11; San Francisco, CA.
  462. Johnson EM, Lanier WA, Merrill RM, Crook J, Porucznik CA, Rolfs RT, Sauer B. Unintentional prescription opioid-related overdose deaths: description of decedents by next of kin or best contact, Utah, 2008-2009. Journal of general internal medicine. 2013 Apr 1; 28(4):522-9.
  463. VA Pharmacy Benefits Management Services, Medical Advisory Panel, and VISN Pharmacist Executives with, Gordon AJ, Kivlahan D, Liberto J, McNicholas L, Oslin DW, Saxon A, Trafton J. Buprenorphine / Naloxone and Buprenorphine Sublingual Formulations for Opioid Dependence. Criteria for Use for Office-Based Opioid Treatment (OBOT) Settings. 2013 Apr 1.
  464. Gordon AJ, Krumm MM. Buprenorphine for opioid dependence. In: Miller PM, editor. Interventions for Addiction: Comprehensive Addictive Behaviors and Disorders. San Diego, CA: Elsevier Inc.; 2013. 417-426 p.
  465. Bohnert AS, Eisenberg A, Whiteside L, Price A, McCabe SE, Ilgen MA. Prescription opioid use among addictions treatment patients: nonmedical use for pain relief vs. other forms of nonmedical use. Addictive Behaviors. 2013 Mar 1; 38(3):1776-81.
  466. Carbone LD, Chin AS, Lee TA, Burns SP, Svircev JN, Hoenig HM, Akhigbe T, Weaver FM. The association of opioid use with incident lower extremity fractures in spinal cord injury. The journal of spinal cord medicine. 2013 Mar 1; 36(2):91-6.
  467. Mallya A, Purnell AL, Svrakic DM, Lovell AM, Freedland KE, Gott BM, Sayuk GS, Cicero TJ, Brawer PA, Trafton JA, Scherrer JF, Lustman PJ. Witnessed versus unwitnessed random urine tests in the treatment of opioid dependence. The American journal on addictions. 2013 Mar 1; 22(2):175-7.
  468. Oliva EM, Trafton JA, Harris AH, Gordon AJ. Trends in opioid agonist therapy in the Veterans Health Administration: is supply keeping up with demand? The American journal of drug and alcohol abuse. 2013 Mar 1; 39(2):103-7.
  469. Painter JT, Crofford LJ. Chronic opioid use in fibromyalgia syndrome: a clinical review. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 2013 Mar 1; 19(2):72-7.
  470. Painter JT, Crofford LJ, Talbert J. Geographic variation of chronic opioid use in fibromyalgia. Clinical therapeutics. 2013 Mar 1; 35(3):303-11.
  471. Dobscha SK, Morasco BJ, Duckart JP, Macey T, Deyo RA. Correlates of prescription opioid initiation and long-term opioid use in veterans with persistent pain. The Clinical Journal of Pain. 2013 Feb 1; 29(2):102-8.
  472. Fiellin LE, Tetrault JM, Becker WC, Fiellin DA, Hoff RA. Previous use of alcohol, cigarettes, and marijuana and subsequent abuse of prescription opioids in young adults. The Journal of adolescent health : official publication of the Society for Adolescent Medicine. 2013 Feb 1; 52(2):158-63.
  473. Edelman EJ, Gordon K, Becker WC, Goulet JL, Skanderson M, Gaither JR, Brennan Braden J, Gordon AJ, Kerns RD, Justice AC, Fiellin DA. Receipt of opioid analgesics by HIV-infected and uninfected patients. Journal of general internal medicine. 2013 Jan 1; 28(1):82-90.
  474. Hausmann LR, Gao S, Lee ES, Kwoh CK. Racial disparities in the monitoring of patients on chronic opioid therapy. Pain. 2013 Jan 1; 154(1):46-52.
  475. Morasco BJ, Turk DC, Donovan DM, Dobscha SK. Risk for prescription opioid misuse among patients with a history of substance use disorder. Drug and Alcohol Dependence. 2013 Jan 1; 127(1-3):193-9.
  476. Wang KH, Becker WC, Fiellin DA. Prevalence and correlates for nonmedical use of prescription opioids among urban and rural residents. Drug and Alcohol Dependence. 2013 Jan 1; 127(1-3):156-62.
  477. Dobscha SK. Critical Review of Recent Research Findings—Opioid Use and Misuse. Presented at: Academy of Psychosomatic Medicine Annual Meeting; 2012 Nov 15; Atlanta, GA.
  478. Bailey FA, Williams BR, Goode PS, Woodby LL, Redden DT, Johnson TM, Taylor JW, Burgio KL. Opioid pain medication orders and administration in the last days of life. Journal of pain and symptom management. 2012 Nov 1; 44(5):681-91.
  479. Carroll I, Barelka P, Wang CK, Wang BM, Gillespie MJ, McCue R, Younger JW, Trafton J, Humphreys K, Goodman SB, Dirbas F, Whyte RI, Donington JS, Cannon WB, Mackey SC. A pilot cohort study of the determinants of longitudinal opioid use after surgery. Anesthesia and analgesia. 2012 Sep 1; 115(3):694-702.
  480. Zickmund SL, Campbell SA, Tirado CF, Zook CL, Weinrieb RM. Perceived barriers to hepatitis C therapy for patients receiving opioid agonist treatment. Journal of addiction medicine. 2012 Sep 1; 6(3):233-9.
  481. Becker WC, Fiellin DA. Federal plan for prescriber education on opioids misses opportunities. Annals of internal medicine. 2012 Aug 7; 157(3):205-6.
  482. Gordon AJ. An implementation model for addiction pharmacotherapy: buprenorphine for opioid dependence [remote presentation to VISN 21/22 Strategic Planning Meeting FY13: Academic Detailing Pilot on Use of Face to Face Education with Powerful Informatics Tools to Improve Quality of Care, Long Beach, CA]. 2012 Jul 26.
  483. Hawkins EJ, Malte C, Imel ZE, Saxon AJ, Grossbard JR, Kivlahan DR. Prevalence and Trends in Benzodiazepine and Concomitant Opioid Analgesics Use among VA Patients with PTSD, 2003-2010. Presented at: VA HSR&D / QUERI National Meeting; 2012 Jul 19; National Harbor, MD.
  484. Bohnert AS, Pfeiffer PN, Ganoczy D, Ilgen MA, Valenstein MT, Eisenberg AM, Blow FC. The Association of Length of Opioid Therapy and Days Since Last Opioid Fill with Opioid Overdose Death. Paper presented at: VA HSR&D / QUERI National Meeting; 2012 Jul 17; National Harbor, MD.
  485. Hausmann LR, Gao S, Lee ES, Kwoh CK. Racial disparities in the monitoring of patients on chronic opioid therapy. Paper presented at: VA HSR&D / QUERI National Meeting; 2012 Jul 17; National Harbor, MD.
  486. Krebs EE, Matthias MS, Bergman AB, Coffing J, Campbell S, Frankel RM. Perceptions of opioid monitoring in VA primary care: "We just home they don't call back.". Poster session presented at: VA HSR&D / QUERI National Meeting; 2012 Jul 14; National Harbor, MD.
  487. Bohnert AS, Blow FC. The association between opioid prescribing patterns and opioid overdose-related deaths. Paper presented at: College on Problems of Drug Dependence Annual Meeting; 2012 Jun 12; Palm Springs, CA.
  488. Bohnert AS. Recent non-medical prescription opioid use among adult patients at an inner-city emergency department. Paper presented at: College on Problems of Drug Dependence Annual Meeting; 2012 Jun 11; Palm Springs, CA.
  489. Gordon KS, Edelman EJ, Becker WC, Skanderson M, Gaither J, Brennan Braden J, Goulet JL, Gordon AJ, Kerns RD, Justice AC, Fiellin DA. Opioid prescribing among HIV-infected and uninfected patients. Poster session presented at: American Pain Society Annual Meeting; 2012 May 16; Honolulu, HI.
  490. Gordon AJ. Buprenorphine for opioid dependence. In: Miller PM, editor. Encyclopedia of Addictive Behaviors. Vol. 3 ed. Oxford, England: Academic Press; 2012. Chapter 44.
  491. Edelman EJ, Gordon KS, Becker W, Goulet JL, Skanderson M, Gaither JR, Braden JB, Gordon AJ, Kerns R, Justice AC, Fiellin DA. HIV status is an independent predictor of receiving opioid analgesics. Paper presented at: Society of General Internal Medicine Annual Meeting; 2012 May 12; Orlando, FL.
  492. Becker WC. Trends in prevalence of non-medical use and prescription opioid abuse/dependence in the U.S., 2000-2009. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2012 May 9; Orlando, FL.
  493. Bergman AB, Matthias MS, Coffing JM, Krebs EE. Managing chronic pain with opioid medications: Patient voices. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2012 May 1; Orlando, FL.
  494. Oliva EM, Harris AH, Trafton JA, Gordon AJ. Receipt of opioid agonist treatment in the Veterans Health Administration: facility and patient factors. Drug and Alcohol Dependence. 2012 May 1; 122(3):241-6.
  495. Krebs EE. Barriers to Opioid Monitoring in Primary Care. [Cyberseminar]. 2012 Apr 3.
  496. Skinner MA, Lewis ET, Trafton JA. Opioid use patterns and association with pain severity and mental health functioning in chronic pain patients. Pain medicine (Malden, Mass.). 2012 Apr 1; 13(4):507-17.
  497. Becker WC. Opioids for Chronic Non-Cancer Pain: Knowledge, Skills, and Attitudes. Poster session presented at: Society of General Internal Medicine New England Regional Annual Meeting; 2012 Mar 9; Portland, ME.
  498. Seal KH, Shi Y, Cohen G, Cohen BE, Maguen S, Krebs EE, Neylan TC. Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA. 2012 Mar 7; 307(9):940-7.
  499. Bergman AB, Coffing J, Matthias MS, Krebs EE. Managing chronic pain with opioid medications: Patients voices. Journal of general internal medicine. 2012 Mar 1; 27(S2):S243.
  500. Midboe AM, Lewis ET, Paik MC, Gallagher RM, Rosenberg JM, Goodman F, Kerns RD, Becker WC, Trafton JA. Measurement of adherence to clinical practice guidelines for opioid therapy for chronic pain. Translational behavioral medicine. 2012 Mar 1; 2(1):57-64.
  501. Ray LA, Barr CS, Blendy JA, Oslin D, Goldman D, Anton RF. The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review. Alcoholism, clinical and experimental research. 2012 Mar 1; 36(3):385-94.
  502. Humphreys KN. Public policy on prescription opioids: Are we trapped between Scylla and Charybdis? Invited Plenary. Presented at: American Academy of Pain Medicine Annual Meeting; 2012 Feb 25; Palm Springs, CA.
  503. Sauer BC. Physician specialty and opioid prescribing in the Utah controlled substance database, 2005-2009. [Abstract]. Pain medicine (Malden, Mass.). 2012 Feb 1.
  504. Britton PC, Bohnert AS, Wines JD, Conner KR. A procedure that differentiates unintentional from intentional overdose in opioid abusers. Addictive Behaviors. 2012 Jan 1; 37(1):127-30.
  505. Quest TL, Merrill JO, Roll J, Saxon AJ, Rosenblatt RA. Buprenorphine therapy for opioid addiction in rural Washington: the experience of the early adopters. Journal of opioid management. 2012 Jan 1; 8(1):29-38.
  506. Trafton JA, Lewis ET, Midboe AM, Paik M, Kerns R, Gallagher R, Rosenberg J, Becker W, Goodman F. Measures to assess adherence to prescription opioid guidelines in the United States Veterans Health Administration. Poster session presented at: Society for the Study of Addiction Annual Symposium; 2011 Nov 10; York, United Kingdom.
  507. Bohnert AS, Blow FC, Bair MJ. Opioid overdose related deaths. [Letter to the Editor]. Journal of The American Medical Association. 2011 Nov 1; 306(1):380-81.
  508. Deyo RA, Smith DH, Johnson ES, Donovan M, Tillotson CJ, Yang X, Petrik AF, Dobscha SK. Opioids for back pain patients: primary care prescribing patterns and use of services. Journal of the American Board of Family Medicine : JABFM. 2011 Nov 1; 24(6):717-27.
  509. Matthias MS, Bergman AB, Bair MJ, Coffing JM, Collins LA, Krebs EE. "I'm not abusing or anything": Patient provider communication about opioid treatment. Paper presented at: International Conference on Communication in Healthcare; 2011 Oct 17; Chicago, IL.
  510. Macey TA, Morasco BJ, Duckart JP, Dobscha SK. Patterns and correlates of prescription opioid use in OEF/OIF veterans with chronic noncancer pain. Pain medicine (Malden, Mass.). 2011 Oct 1; 12(10):1502-9.
  511. Carbone L, Chin A, Lee TA, Burns S, Svircev J, Hoening H, Akhigbe T, Weaver FM. Anticonvulsant and Opioid Use and Fractures in Veterans with Spinal Cord Injury. Poster session presented at: American Society for Bone and Mineral Research Annual Meeting; 2011 Sep 17; San Diego, CA.
  512. Morasco BJ, Duckart JP, Dobscha SK. Adherence to clinical guidelines for opioid therapy for chronic pain in patients with substance use disorder. Journal of general internal medicine. 2011 Sep 1; 26(9):965-71.
  513. Price AM, Ilgen MA, Bohnert AS. Prevalence and correlates of nonmedical use of prescription opioids in patients seen in a residential drug and alcohol treatment program. Journal of substance abuse treatment. 2011 Sep 1; 41(2):208-14.
  514. Bohnert AS. Treatment Prior to Opioid Overdose Death. Paper presented at: VA Mental Health Annual Conference; 2011 Aug 24; Baltimore, MD.
  515. Campbell SR, Matthias MS, Bergman AB, Krebs E. "I feel like I’m not a doctor”: Physicians’ perceptions of opioid management. [Editorial]. Journal of general internal medicine. 2011 Jul 1; 26(S-1):264-5.
  516. Oslin DW. Pharmacogenetics of the mu-opioid receptor for alcohol dependence. Paper presented at: New Clinical Drug Evaluation Unit Annual Meeting; 2011 Jun 13; Fort Lauderdale, FL.
  517. Awosika CO, Sanders SH, Clark ME, Banou E. The Effects of Opioid Use on Veterans with Primary Chronic Headaches Participating in Inpatient Chronic Pain Rehabilitation. Poster session presented at: American Headache Society Annual Meeting; 2011 Jun 4; Washington, DC.
  518. Chan G, Gelernter J, Oslin D, Farrer L, Kranzler HR. Empirically derived subtypes of opioid use and related behaviors. Addiction (Abingdon, England). 2011 Jun 1; 106(6):1146-54.
  519. Porucznik CA, Johnson EM, Sauer B, Crook J, Rolfs RT. Studying adverse events related to prescription opioids: the Utah experience. Pain medicine (Malden, Mass.). 2011 Jun 1; 12 Suppl 2:S16-25.
  520. Dobscha SK, Morasco BJ, Macey T, Duckart J, Deyo RA. Predictors of Opioid Initiation and Long Term Use Among Veterans with Chronic Pain. Poster session presented at: American Psychiatric Association Annual Meeting; 2011 May 16; Honolulu, HI.
  521. Campbell SR, Matthias MS, Bergman AB, Krebs E. "I feel like I’m not a doctor”: Physicians’ perceptions of opioid management. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2011 May 10; Phoenix, AZ.
  522. Barry DT, Goulet JL, Kerns RK, Becker WC, Gordon AJ, Justice AC, Fiellin DA. Nonmedical use of prescription opioids and pain in veterans with and without HIV. Pain. 2011 May 1; 152(5):1133-8.
  523. Gordon AJ. Opioid dependence in the VA: addressing problems of opioid misuse and dependence through evidence based practice. Paper presented at: U.S. Army Alcohol and Other Drug Use Research Strategic Planning Work Group in Prescription Misuse and Abuse; 2011 May 1; Alexandria, VA.
  524. Krebs EE, Ramsey DC, Miloshoff JM, Bair MJ. Primary care monitoring of long-term opioid therapy among veterans with chronic pain. Pain medicine (Malden, Mass.). 2011 May 1; 12(5):740-6.
  525. Trafton JA, Cucciare MA, Lewis E, Oser M. Somatization is associated with non-adherence to opioid prescriptions. The journal of pain : official journal of the American Pain Society. 2011 May 1; 12(5):573-80.
  526. Gordon AJ. Opioid agonist therapy in the VA: trends, barriers, and solutions [symposium]. Presented at: American Society of Addiction Medicine Annual Meeting; 2011 Apr 17; Washington, DC.
  527. Bohnert AS, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA, Blow FC. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011 Apr 6; 305(13):1315-21.
  528. Lewis ET, Trafton JA. Opioid use in primary care: asking the right questions. Current Pain and Headache Reports. 2011 Apr 1; 15(2):137-43.
  529. Cronkite RC, Trafton JA, Chambers DA, Lewis ET, Midboe AM, Kerns R, Martins SB, Wang D, Ghaus S, Goldstein MK. Veterans Health Administration Stakeholders’ Input on Implementation of ATHENA-Opioid Therapy (OT) Clinical Decision Support (CDS) System. Poster session presented at: American Medical Informatics Association on Translational Bioinformatics Research Annual Summit; 2011 Mar 10; San Francisco, CA.
  530. Dobscha SK, Morasco BJ, Macey TA, Duckart JP, Deyo RA. Predictors of Opioid Initiation and Long Term Use Among Veterans with Chronic Pain. Poster session presented at: VA National Pain Management Conference; 2011 Mar 2; Jacksonville, FL.
  531. Macey TA, Morasco BJ, Duckart JP, Dobscha SK. Patterns and Correlates of Prescription Opioid Use in OEF/OIF Veterans. Poster session presented at: VA National Pain Management Conference; 2011 Mar 2; Jacksonville, FL.
  532. Korthuis PT, Fiellin DA, Fu R, Lum PJ, Altice FL, Sohler N, Tozzi MJ, Asch SM, Botsko M, Fishl M, Flanigan TP, Boverman J, McCarty D, BHIVES Collaborative. Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine. Journal of acquired immune deficiency syndromes (1999). 2011 Mar 1; 56 Suppl 1:S83-90.
  533. Bohnert AS, Ilgen MA, Ganoczy D, Valenstein MT, McCarthy JF, Blow FC. Opioid Prescribing and Fatal Opioid Overdose Trends in the VHA, 2000-2007. Paper presented at: VA HSR&D National Meeting; 2011 Feb 18; National Harbor, MD.
  534. Oliva EM, Trafton JA, Sox-Harris A, Gordon AJ. Opioid agonist treatment (OAT) for opioid dependence: Trends in use of buprenorphine and patient and facility factors related to OAT receipt. Paper presented at: VA HSR&D National Meeting; 2011 Feb 18; National Harbor, MD.
  535. Dobscha SK, Morasco BJ, Macey T, Duckart J, Deyo RA. Predictors of Opioid Initiation and Long Term Use Among Veterans with Chronic Pain. Poster session presented at: VA HSR&D National Meeting; 2011 Feb 17; National Harbor, MD.
  536. Morasco BJ, Duckart J, Dobscha SK. Adherence to Clinical Guidelines for the Use of Chronic Opioid Therapy in Veterans with Chronic Pain Based on Substance Use Disorder Status. Poster session presented at: VA HSR&D National Meeting; 2011 Feb 15; National Harbor, MD.
  537. Morasco BJ, Duckart JP, Carr TP, Deyo RA, Dobscha SK. Clinical characteristics of veterans prescribed high doses of opioid medications for chronic non-cancer pain. Pain. 2010 Dec 1; 151(3):625-32.
  538. Stein MD, Herman DS, Kettavong M, Cioe PA, Friedmann PD, Tellioglu T, Anderson BJ. Antidepressant treatment does not improve buprenorphine retention among opioid-dependent persons. Journal of substance abuse treatment. 2010 Sep 1; 39(2):157-66.
  539. Broyles LM, Hanusa BH, Krumm M, Paidisetty S, Forman SD. Comparative outcomes of VA office-based buprenorphine and methadone treatment for opioid dependence in the VA. Paper presented at: VA Implementing a Public Health Model for Meeting the Mental Health Needs of Veterans Annual Mental Health Conference; 2010 Jul 28; Baltimore, MD.
  540. Oliva EM, Trafton JA, Harris AH, Gordon AJ. Trends in Use of Buprenorphine for the Treatment of Opioid Dependence. Paper presented at: VA Implementing a Public Health Model for Meeting the Mental Health Needs of Veterans Annual Mental Health Conference; 2010 Jul 27; Baltimore, MD.
  541. Trafton JA, Lewis E, Martins S, Becker W, Kivlahan D, Harris AH, Kerns B, Gallagher M, Rosenberg J. An Evaluation and Feedback System to Encourage Safe Opioid Prescribing for Chronic Pain. Poster session presented at: VA “One Team toward One Dream” National Quality, Patient Safety and Systems Redesign Conference; 2010 Jun 22; San Francisco, CA.
  542. Goulet JL. Non-medical use of prescription opioids among Veterans with and without HIV: Pain, psychiatric, medical and substance use correlates. Paper presented at: College on Problems of Drug Dependence Annual Meeting; 2010 Jun 20; Reno, NV.
  543. Lewis ET, Combs A, Trafton JA. Reasons for under-use of prescribed opioid medications by patients in pain. Pain medicine (Malden, Mass.). 2010 Jun 1; 11(6):861-71.
  544. Morasco BJ, Duckart JP, Carr TP, Deyo RA, Dobscha SK. Characteristics of Patients Prescribed High Doses of Opioid Medications for Chronic Non-Cancer Pain. Poster session presented at: American Pain Society Annual Meeting; 2010 May 7; Baltimore, MD.
  545. Oser ML, Cucciare MA, Trafton JA. Impact of Somatization on the misuse of prescription opioids. Poster session presented at: Society of Behavioral Medicine Annual Meeting and Scientific Sessions; 2010 Apr 8; Seattle, WA.
  546. Morasco BJ, Duckart JP, Carr TP, Deyo RA, Dobscha SK. Characteristics of patients prescribed high doses of opioid medications for chronic non-cancer pain. [Abstract]. The journal of pain : official journal of the American Pain Society. 2010 Apr 1; 11(Suppl):S45.
  547. Trafton J, Martins S, Michel M, Lewis E, Wang D, Combs A, Scates N, Tu S, Goldstein MK. Evaluation of the acceptability and usability of a decision support system to encourage safe and effective use of opioid therapy for chronic, noncancer pain by primary care providers. Pain medicine (Malden, Mass.). 2010 Apr 1; 11(4):575-85.
  548. Tuteja AK, Biskupiak J, Stoddard GJ, Lipman AG. Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain. Neurogastroenterology and Motility : The Official Journal of The European Gastrointestinal Motility Society. 2010 Apr 1; 22(4):424-30, e96.
  549. Krebs EE, Lurie JD, Fanciullo G, Tosteson TD, Blood EA, Carey TS, Weinstein JN. Predictors of long-term opioid use among patients with painful lumbar spine conditions. The journal of pain : official journal of the American Pain Society. 2010 Jan 1; 11(1):44-52.
  550. Sauer BC. Adult Use of Prescription Opioid Pain Medications—Utah, 2008. JAMA. 2010 Jan 1; 303(14):1359-1361.
  551. Dosa DM, Dore DD, Mor V, Teno JM. Frequency of long-acting opioid analgesic initiation in opioid-naïve nursing home residents. Journal of pain and symptom management. 2009 Oct 1; 38(4):515-21.
  552. Trafton JA. Decision support for the management of opioid therapy in chronic pain. [Cyberseminar]. 2009 Sep 23.
  553. Lewis E, Trafton JA. Resisting opioid therapy: Strategies patients use with health care providers. Paper presented at: American Sociological Association Annual Meeting; 2009 Aug 8; San Francisco, CA.
  554. Broyles LM, Paidisetty S, Forman SD, Krumm MM, Gordon AJ. Buprenorphine and methadone opioid agonist therapy: differences in patient enrollment characteristics within a VA medical center. Poster session presented at: VA MIRECC Annual Best Practices in Mental Health Conference; 2009 Jul 21; Washington, DC.
  555. Michel M, Trafton JA, Martins SB, Wang D, Tu S, Johnson NA, Goldstein MK. Improving Patient Safety using ATHENA-Decision Support System Technology: Opioid Therapy for Chronic Pain. AHRQ Advances in Patient Safety: New Directions and Alternative Approaches. 2009 Jul 1; Vol 4.
  556. Mitchell SG, Kelly SM, Brown BS, Reisinger HS, Peterson JA, Ruhf A, Agar MH, Schwartz RP. Incarceration and opioid withdrawal: the experiences of methadone patients and out-of-treatment heroin users. Journal of Psychoactive Drugs. 2009 Jun 1; 41(2):145-52.
  557. Bair MJ. Providers’ Perspectives on Urine Drug Testing and Opioids. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2009 May 1; Miami, FL.
  558. Banta-Green CJ, Maynard C, Koepsell TD, Wells EA, Donovan DM. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users. Addiction. 2009 May 1; 104(5):775-83.
  559. Rose AJ, Hermos JA, Frayne SM, Pogach LM, Berlowitz DR, Miller DR. Does opioid therapy affect quality of care for diabetes mellitus? The American journal of managed care. 2009 Apr 1; 15(4):217-24.
  560. Johnson E, Rolfs R, Porucznik C, Sauer BC. Utah's Education Campaign for Prescription Opioids. Poster session presented at: American Academy of Pain Medicine Annual Meeting; 2009 Jan 28; Honolulu, HI.
  561. Kelly SM, Schwartz RP, O'Grady KE, Mitchell SG, Reisinger HS, Peterson JA, Agar MH, Brown BS. Gender Differences Among In- and Out-of-Treatment Opioid-Addicted Individuals. The American journal of drug and alcohol abuse. 2009 Jan 1; 35(1):38-42.
  562. Kim SG, Kim CM, Choi SW, Jae YM, Lee HG, Son BK, Kim JG, Choi YS, Kim HO, Kim SY, Oslin DW. A micro opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patients. Psychopharmacology. 2009 Jan 1; 201(4):611-8.
  563. Burgess DJ, Crowley-Matoka M, Phelan S, Dovidio JF, Kerns R, Roth C, Saha S, van Ryn M. Patient race and physicians' decisions to prescribe opioids for chronic low back pain. Social science & medicine (1982). 2008 Dec 1; 67(11):1852-60.
  564. Phillips KA, Walley AY, Gordon AJ. Patients in recovery (PIR): success at teaching opioid addiction treatments to physicians. Poster session presented at: Association for Medical Education and Research in Substance Abuse Annual Meeting; 2008 Nov 6; Washington, DC.
  565. Roth CS, Burgess DJ. Changing residents' beliefs and concerns about treating chronic noncancer pain with opioids: evaluation of a pilot workshop. Pain medicine (Malden, Mass.). 2008 Oct 1; 9(7):890-902.
  566. Hudson TJ, Edlund MJ, Steffick DE, Tripathi SP, Sullivan MD. Epidemiology of regular prescribed opioid use: results from a national, population-based survey. Journal of pain and symptom management. 2008 Sep 1; 36(3):280-8.
  567. Mangione MP, Crowley-Matoka M. Improving pain management communication: how patients understand the terms "opioid" and "narcotic". Journal of general internal medicine. 2008 Sep 1; 23(9):1336-8.
  568. Schwartz RP, Kelly SM, O'Grady KE, Mitchell SG, Peterson JA, Reisinger HS, Agar MH, Brown BS. Attitudes toward buprenorphine and methadone among opioid-dependent individuals. The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 2008 Sep 1; 17(5):396-401.
  569. Mooney ME, Poling J, Gonzalez G, Gonsai K, Kosten T, Sofuoglu M. Preliminary study of buprenorphine and bupropion for opioid-dependent smokers. The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 2008 Aug 1; 17(4):287-92.
  570. Dobscha SK, Corson K, Flores JA, Tansill EC, Gerrity MS. Veterans affairs primary care clinicians' attitudes toward chronic pain and correlates of opioid prescribing rates. Pain medicine (Malden, Mass.). 2008 Jul 1; 9(5):564-71.
  571. Whitehead AJ, Dobscha SK, Morasco BJ, Ruimy S, Bussell C, Hauser P. Pain, substance use disorders and opioid analgesic prescription patterns in veterans with hepatitis C. Journal of pain and symptom management. 2008 Jul 1; 36(1):39-45.
  572. Friedly J, Nishio I, Bishop MJ, Maynard C. The relationship between repeated epidural steroid injections and subsequent opioid use and lumbar surgery. Archives of physical medicine and rehabilitation. 2008 Jun 1; 89(6):1011-5.
  573. Carroll I, Wang J, Wang C, Gillespie M, Barelka P, Humphreys K, Trafton J. Risk factors for delayed opioid cessation following surgery. Poster session presented at: American Pain Society Annual Meeting; 2008 May 9; Tampa, FL.
  574. Trafton JA. Improving Delivery of Evidence-Based Opioid Therapy: The ATHENA-Opioid Decision Support System. Paper presented at: American Pain Society Annual Meeting; 2008 May 9; Tampa, FL.
  575. Bair MJ. Opioids for Chronic Pain, Chronic Disease Care and Management. Paper presented at: Society of General Internal Medicine Annual Meeting; 2008 Apr 9; Pittsburgh, PA.
  576. Grosheider T, Luther J, Ramgopal R, Gordon AJ. Physician attitudes toward harm reduction in office-based opioid agonist therapy. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2008 Apr 9; Pittsburgh, PA.
  577. Phillips K, Gordon AJ, Walley AY. Patients in recovery and opioids. Paper presented at: Society of General Internal Medicine Annual Meeting; 2008 Apr 9; Pittsburgh, PA.
  578. Rose AJ, Hermos J, Frayne S, Pogach L, Berlowitz D, Miller D. Do Opioids Affect Quality of Diabetes Care? Poster session presented at: Society of General Internal Medicine Annual Meeting; 2008 Apr 9; Pittsburgh, PA.
  579. Rose AJ, Hermos, Frayne SM, Pogach LM, Berlowitz DR, Miller DR. Do opioids affect quality of care for diabetes mellitus? Paper presented at: Society of General Internal Medicine Annual Meeting; 2008 Apr 1; Toronto, Canada.
  580. Schwartz RP, Kelly SM, O'Grady KE, Peterson JA, Reisinger HS, Mitchell SG, Wilson ME, Agar MH, Brown BS. In-treatment vs. out-of-treatment opioid dependent adults: drug use and criminal history. The American journal of drug and alcohol abuse. 2008 Mar 19; 34(1):17-28.
  581. Burgess DJ, van Ryn M, Dovidio J, Matoka MC, Saha S, Phelan S, Roth C, Kerns R. Patient Race and Physicians’ Decisions to Prescribe Opioids for Chronic Low Back Pain. Paper presented at: VA HSR&D National Meeting; 2008 Feb 14; Baltimore, MD.
  582. Trafton JA, Nevinslong L. ATHENA-Opioid Therapy: A Computerized Decision Support System for Treatment of Chronic Non-Cancer Pain, 11/8/07. 2007 Nov 8.
  583. Trafton JA, Humphreys K, Harris AH, Oliva E. Consistent adherence to guidelines improves opioid dependent patients' first year outcomes. The journal of behavioral health services & research. 2007 Jul 1; 34(3):260-71.
  584. Michel MC, Martins SB, Wang D, Daniels D, Tu S, Coleman R, Musen M, Trafton J. ATHENA DDS: From hypertension to managing opioid therapy for chronic pain, a progress report. Poster session presented at: National Library of Medicine Informatics Training Course; 2007 Jun 27; Palo Alto, CA.
  585. Edlund MJ, Steffick D, Hudson T, Harris KM, Sullivan M. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain. 2007 Jun 1; 129(3):355-62.
  586. Oderda GM, Said Q, Evans RS, Stoddard GJ, Lloyd J, Jackson K, Rublee D, Samore MH. Opioid-related adverse drug events in surgical hospitalizations: impact on costs and length of stay. The Annals of pharmacotherapy. 2007 Mar 1; 41(3):400-6.
  587. Trafton JA, Tracy SW, Oliva EM, Humphreys K. Different components of opioid-substitution treatment predict outcomes of patients with and without a parent with substance-use problems. Journal of Studies On Alcohol. 2007 Mar 1; 68(2):165-72.
  588. Dobscha SK, Flores JA, Leibowitz RQ, Cockrell E, Gerrity MS. Examining relationships between clinician attitudes about chronic pain and opioid prescribing rates. Poster session presented at: VA HSR&D National Meeting; 2007 Feb 23; Arlington, VA.
  589. Edlund MJ, Steffick D, Sullivan M, Hudson TJ, Harris KM. Risk factors for diagnosed opioid abuse and dependence among individuals using opioids for chronic non-cancer pain. Poster session presented at: VA HSR&D National Meeting; 2007 Feb 22; Arlington, VA.
  590. Hickam D, Chou R, King V, Bianco T, Robinson S, Schechtel M. Choosing non-opioid analgesics for osteoarthritis: clinicians' guide. Rockville, MD: Agency for Healthcare Research and Quality; 2007 Jan 1. Report No.: 6(07)-EHC009-3.
  591. Roth CS, Burgess DJ, Mahowald ML. Medical residents' beliefs and concerns about using opioids to treat chronic cancer and noncancer pain: a pilot study. Journal of rehabilitation research and development. 2007 Jan 1; 44(2):263-70.
  592. Stein MD, Friedmann PD. Optimizing opioid detoxification: rearranging deck chairs on the Titanic. Journal of addictive diseases. 2007 Jan 1; 26(2):1-2.
  593. Barnett PG, Masson CL, Sorensen JL, Wong W, Hall S. Linking opioid-dependent hospital patients to drug treatment: Health care use and costs 6 months after randomization. Addiction. 2006 Dec 1; 101(12):1797-804.
  594. Dobscha SK, Flores JA, Leibowitz RQ, Cockrell E, Gerrity MS. Examining relationships between clinician attitudes about chronic pain and opioid prescribing rates. Poster session presented at: Academy of Psychosomatic Medicine Annual Meeting; 2006 Nov 16; Tucson, AZ.
  595. Pletcher MJ, Kertesz SG, Sidney S, Kiefe CI, Hulley SB. Incidence and antecedents of nonmedical prescription opioid use in four US communities. The Coronary Artery Risk Development in Young Adults (CARDIA) prospective cohort study. Drug and Alcohol Dependence. 2006 Nov 8; 85(2):171-6.
  596. Carey T, Krebs E. Review: opioids are more effective than placebo but not other analgesics for chronic noncancer pain. ACP journal club. 2006 Nov 1; 145(3):74.
  597. Sullivan MD, Edlund MJ, Zhang L, Unützer J, Wells KB. Association between mental health disorders, problem drug use, and regular prescription opioid use. Archives of internal medicine. 2006 Oct 23; 166(19):2087-93.
  598. Wu SM, Compton P, Bolus R, Schieffer B, Pham Q, Baria A, Van Vort W, Davis F, Shekelle P, Naliboff BD. The addiction behaviors checklist: validation of a new clinician-based measure of inappropriate opioid use in chronic pain. Journal of pain and symptom management. 2006 Oct 1; 32(4):342-51.
  599. Vogt MT, Starz TW, Kwoh CK. Opioid usage among older adults with low back pain: comment on the article by Solomon et al. [Editorial]. Arthritis Rheum. 2006 Jun 15; 55(3):513; author reply 513-4.
  600. Boockvar KS. Discontinuation of standing opioid orders in individuals transferred from nursing home to hospital. Presented at: American Geriatrics Society Annual Meeting; 2006 May 1; Chicago, IL.
  601. Kaur S, Stechuchak K, Allen KD, Coffman CJ, Bastian L. Gender differences in opioid prescription among veterans with chronic pain. Paper presented at: Society of General Internal Medicine Annual Meeting; 2006 Apr 1; Los Angeles, CA.
  602. Trafton JA, Minkel J, Humphreys K. Determining effective methadone doses for individual opioid-dependent patients. PLoS Medicine. 2006 Mar 1; 3(3):e80.
  603. Trafton JA, Minkel J, Humphreys K. Opioid substitution treatment reduces substance use equivalently in patients with and without posttraumatic stress disorder. Journal of Studies On Alcohol. 2006 Mar 1; 67(2):228-35.
  604. Sullivan MD, Edlund MJ, Steffick D, Unützer J. Regular use of prescribed opioids: association with common psychiatric disorders. Pain. 2005 Dec 15; 119(1-3):95-103.
  605. Ray R, Doyle GA, Crowley JJ, Buono RJ, Oslin DW, Patkar AA, Mannelli P, DeMaria PA, O'Brien CP, Berrettini WH. A functional prodynorphin promoter polymorphism and opioid dependence. Psychiatric Genetics. 2005 Dec 1; 15(4):295-8.
  606. Edlund MJ, Sullivan M, Steffick D, Harris K. Do Users of Regularly Prescribed Opioids Have Higher Rates of Substance Abuse Problems than Non-Users? Poster session presented at: Addiction Health Services Research Conference; 2005 Oct 26; Santa Monica, CA.
  607. Humphreys K, Trafton JA, Oliva E. Does following practice guidelines matter in the real world of heroin dependence treatment: Multisite Opioid Substitution Treatment Study. Paper presented at: VA HSR&D National Meeting; 2005 Jun 26; Boston, MA.
  608. Trafton JA, Minkel JD, Humphreys K. Posttraumatic stress disorder does not impair substance use disorder outcomes in opioid substitution treatment. Paper presented at: VA HSR&D National Meeting; 2005 Jun 26; Boston, MA.
  609. Chwastiak LA, Goulet J, Bryant KJ, Conigliaro J, Crystal S, Day NL, Fiellin DA, O'Connor P, Rimland D, Rodriguez-Barradas M, Justice AC. Prescribing patterns of opioid pain medications and benzodiazepines among HIV positive and HIV negative patients in the national VA system. Paper presented at: Society of General Internal Medicine Annual Meeting; 2005 May 1; New Orleans, LA.
  610. Smith RJ, Doyle GA, Han AM, Crowley JJ, Oslin DW, Patkar AA, Mannelli P, Demaria PA, O'brien CP, Berrettini WH. Novel exonic mu-opioid receptor gene (OPRM1) polymorphisms not associated with opioid dependence. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. 2005 Feb 5; 133(1):105-9.
  611. Willenbring ML, Hagedorn HJ, Postier AC, Kenny M. Variations in evidence-based clinical practices in nine United States Veterans Administration opioid agonist therapy clinics. Drug and Alcohol Dependence. 2004 Jul 15; 75(1):97-106.
  612. Kim SG, Kim CM, Kang DH, Kim YJ, Byun WT, Kim SY, Park JM, Kim MJ, Oslin DW. Association of functional opioid receptor genotypes with alcohol dependence in Koreans. Alcoholism, clinical and experimental research. 2004 Jul 1; 28(7):986-90.
  613. Willenbring ML, Hagedorn HJ, Kenny ME, Pexa NA, Thuras P. The Opiate Agonist Therapy Effectiveness Initiative: Improving Treatment for Opioid Dependence. Paper presented at: College on Problems of Drug Dependence Annual Meeting; 2004 Jun 1; San Juan, Puerto Rico.
  614. Trafton JA, Basbaum AI. [d-Ala2,N-MePhe4,Gly-ol5]enkephalin-induced internalization of the micro opioid receptor in the spinal cord of morphine tolerant rats. Neuroscience. 2004 Apr 1; 125(3):541-3.
  615. Trafton J, Oliva E, Horst DA, Minkel JD, Humphreys KN. Clinical practices and outcomes in opioid substitution programs: 6-month outcomes. Meeting the changing needs of veterans: the quality/cost equation. Paper presented at: VA HSR&D National Meeting; 2004 Mar 2; Washington, DC.
  616. Willenbring ML, Hagedorn H. Implementing evidence-based practices in opioid agonist clinics. In: Roberts AR, Yeager KR, editors. Evidence-Based Practice Manual: Research and Outcome Measures in Health and Human Services. New York, NY: Oxford University Press; 2004. Chapter 35. 340-347 p.
  617. Oslin DW, Berrettini W, Kranzler HR, Pettinati H, Gelernter J, Volpicelli JR, O'Brien CP. A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Paper presented at: American College of Neuropsychopharmacology Annual Meeting; 2003 Dec 7; San Juan, Puerto Rico.
  618. Ardery G, Herr K, Hannon BJ, Titler MG. Lack of opioid administration in older hip fracture patients (CE). Geriatric nursing (New York, N.Y.). 2003 Nov 1; 24(6):353-60.
  619. Tamayo-Sarver JH, Dawson NV, Hinze SW, Cydulka RK, Wigton RS, Albert JM, Ibrahim SA, Baker DW. The effect of race/ethnicity and desirable social characteristics on physicians' decisions to prescribe opioid analgesics. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 2003 Nov 1; 10(11):1239-48.
  620. Crowley JJ, Oslin DW, Patkar AA, Gottheil E, DeMaria PA, O'Brien CP, Berrettini WH, Grice DE. A genetic association study of the mu opioid receptor and severe opioid dependence. Psychiatric Genetics. 2003 Sep 1; 13(3):169-73.
  621. Oslin DW, Berrettini W, Kranzler HR, Pettinati H, Gelernter J, Volpicelli JR, O'Brien CP. A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology. 2003 Aug 1; 28(8):1546-52.
  622. Goodman F, Gordon A, Kivlahan D, Dalack G, Pope J, McNicholas L, Suchinsky R. Criteria for non-formulary use of buprenorphine sublingual tablets for opioid dependence. VHA Pharmacy Benefits Management Strategic Healthcare Group and the Medical Advisory Panel; 2003 Jun 15.
  623. Oslin DW, Berrettini W, Kranzler HR, Pettinati HM, Gelernter J, Volpicelli JR, O'Brien CP. A functional polymorphism of the mu-opioid receptor gene is associated with therapeutic response in alcohol dependent patients treated with naltrexone. Presented at: Research Society on Alcoholism Annual Scientific Meeting; 2003 Jun 1; Fort Lauderdale, FL.
  624. Rowbotham MC, Twilling L, Davies PS, Reisner L, Taylor K, Mohr D. Oral opioid therapy for chronic peripheral and central neuropathic pain. The New England journal of medicine. 2003 Mar 27; 348(13):1223-32.
  625. Trafton J, Oliva E, Horst D, Minkel J, Humphreys K. Chronic pain and medical, psychiatric, and drug abuse problems in opioid dependent veterans. Paper presented at: VA HSR&D National Meeting; 2003 Feb 1; Washington, DC.
  626. Fillingim RB, Doleys DM, Edwards RR, Lowery D. Clinical characteristics of chronic back pain as a function of gender and oral opioid use. Spine (Philadelphia, Pa. : 1986). 2003 Jan 15; 28(2):143-50.
  627. Wasserman DA, Stewart AL, Delucchi KL. Social support and abstinence from opiates and cocaine during opioid maintenance treatment. Drug and Alcohol Dependence. 2001 Dec 1; 65(1):65-75.
  628. DeMarco F, Calsyn D, Saxon A, Sloan K, Gibbon K. Alternatives to discharge: Two-year outcomes of a 'minimal services' program for non-compliant opioid substitution clients. Annals of behavioral medicine : a publication of the Society of Behavioral Medicine. 2001 Sep 15; 23:S153.
  629. Trafton J, Barnett P, Finney J, Moos RH, Willenbring M, Humphreys K. Effective Treatment of Opioid Dependence. VA Practice Matters. 2001 Jun 1; 6:1-6.
  630. DeMarco F, Calsyn D, Saxon A, Sloan K, Gibbon K. Evaluation of a 'minimal services' treatment track as an alternative to discharge for non-compliant patients in opioid substitution treatment. Drug and Alcohol Dependence. 2000 Oct 15; 60:S30.